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Abstract 
T cell development begins with the migration of early progenitors from the bone marrow 
to the thymus. Once out of the thymus, naïve T cells are held in an inactive state until 
they encounter their cognate antigen/MHC complex to further differentiate into effector T 
cells. Many studies have shown that Wnt signaling is a crucial pathway that regulates 
many aspects of T cell biology from development to effector T cell polarization, 
however, little is known about the role of Wnt in naïve T cells. In this study, we show 
that Adenomatous polyposis coli (APC) is critical for the maintenance of naïve T cells. 
Wnt signaling has also been linked to cancers, though Wnt’s association with 
autoimmune disease is less known. Here, we show an association between ectopic 
dysregulation of Wnt causing a T-cell driven autoimmunity with a Crohn’s disease-like 
phenotype. 
Using an Apc conditional allele that has loxP sites inserted into introns 13 and 14 of the 
endogenous Apc gene under the control of a T cell specific cre-recombinase, CD4-Cre 
or Lck-cre, we can delineate the function of Apc in T cells. Flow cytometry, survival 
curves, and immunohistochemistry were used to study the T cell phenotype and 
autoimmune disease caused by ectopic activation of Wnt. Creation of bone marrow 
chimeras allowed us to investigate whether this T cell phenotype was cell-intrinsic and  
xi 
 
whether the observed autoimmunity was linked to homeostatic proliferation. Using an 
exon 3 deletion of cMyc, we studied the impact of transcriptional activation of cMyc. 
Though an Apc deficiency does not affect thymocyte development, we show that it does  
causes a massive cell-intrinsic loss of peripheral naïve T cells. We concluded that loss 
of Apc not only causes a loss of naïve T cells due to cMyc-induced apoptosis, but also 
results in highly activated T cells that drives the development of a Crohn’s disease-like 
phenotypes. Our study has further linked ectopic Wnt activation to autoimmunity 
through a T cell specific deletion of Apc, suggesting a direct role of Wnt in regulating T 
cell driven etiology of autoimmunity.
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Chapter 1 
Introduction 
1.1 Overview of Wnt signaling  
The term “Wnt” is derived from the drosophila segment polarity gene Wingless (Wg) [3, 
4]  and the human homologue and proto-oncogene Int1 [5-10]; a gene found to be 
activated in mouse mammary tumors. Wnt signaling exerts regulation on many 
developmental pathways, ranging from cell fate determination to maintaining the self-
proliferative properties of stem cells [11-17]. Wnt signaling can be categorized into the 
canonical pathway or the noncanonical pathway. The canonical Wnt signaling pathway, 
as diagramed in Fig. 1, regulates transcriptional activity of -catenin. The noncanonical 
pathways are independent to β-catenin and TCF/LEF. The WNT-Ca2+, which regulates 
cell fate, migration, and the planar cell polarity (PCP) pathway (regulates cell polarity) 
are examples of the noncanonical pathways [11, 13, 16]. 
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Figure 1.1.  Diagram of canonical Wnt signaling pathway (adapted from [18]) a. Under circumstances 
where no Wnt ligand is present, β-catenin is targeted by the destruction complex, which consists of CK1, 
APC, Axin, and GSK-3 β. GSK-3 β phosphorylates β-catenin, leading to its ubiquitination and proteasomal 
degradation by the β-TrCP/SKP pathway. Thus, β-catenin does not translocate into the nucleus and Wnt 
signaling is not activated. b. Wnt binds to the co-receptors LRP5/6 and Frizzled, leading to inactivation of 
Dishveled and the ablation of the destruction complex. As a result, β-catenin is and translocated into the 
nucleus where it binds to its partners, such as TCF-1/LEF-and activate Wnt signaling.  
 
As seen in Fig 1.1a, in the absence of Wnt proteins, basal levels of β-catenin are low 
due to the action of “destruction complex” composed of the tumor suppressor 
adenomatous polyposis coli (APC), GSK-3β, and Axin[19]. APC is the scaffold, by which 
“destruction complex” forms [20]. GSK-3β, then, phosphorylates β-catenin at four N-
terminal serine and threonine residues [21, 22]. This phosphorylation event results in 
recognition by β-TrCP, and thus ubiquitinates β-catenin, labeling β-catenin to be 
degraded by the proteasome [11, 13, 16, 23].  
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 Wnt proteins that initiate canonical Wnt signaling are a family of cysteine-rich 
glycoproteins [13, 24, 25]. These Wnt proteins serve as the ligands for the Frizzled (Fz) 
family of serpentine receptors [26-29] . Together with Fz, low-density lipoprotein 
receptor-related proteins (LRP-5 and -6)[30-33] bind to Wnt proteins to activate the Wnt 
cascade that results in inactivation of glycogen synthase kinase 3β (GSK3β) by a 
cytoplasmic protein known as Dishevelled, Dvl (Fig 1b) [34-38]. This results in the 
accumulation of β-catenin in the cytoplasm, and subsequent translocation into the 
nucleus, where it binds to members of the TCF/LEF family of transcription factors 
thereby activating Wnt target genes [11, 13, 16, 39-41]. 
Emerging evidence has shown that canonical Wnt signaling is important in the 
regulation of thymopoiesis and T cell differentiation, however, its role in naïve T cells is 
still unknown. Therefore by employing a conditional knockout of the Apc gene controlled 
by CD4-cre, we can ectopically activate Wnt signaling in later stages of T cell 
development, allowing us to further elucidate the role of Wnt in naïve T cells. Activation 
of Wnt initiates the upregulation of many downstream proteins that are regulators of the 
cell cycle, such as c-Myc [42, 43]. Interestingly, although c-Myc is known as an 
oncogene overexpressed in many cancers, c-Myc, in T cells, has be implicated in 
apoptosis via Fas/FasL interaction, death ligand tumor necrosis factor, and tumor 
necrosis factor related apoptosis-inducing ligand [44-46]. In this study, using a 
conditional knockout of Apc, we investigated the role of Wnt signaling and the effects of 
the upregulation of the known Wnt target gene, cMyc, in naïve T cells. 
1.2 APC: Adenomatous Polyposis Coli 
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APC, a gene located on chromosome 5 in humans, was first identified as a tumor 
suppressor responsible for the onset of a rare autosomal dominant form of colorectal 
cancer known as familial adenomatous polyposis (FAP)[47-52].  It is somatically 
mutated in 80% of colorectal cancer and has been identified as the earliest known 
genetic alteration in colorectal cancers [53-55]. The mutation cluster region (MCR), 
found within the APC gene, is where the majority of colorectal cancer mutations are 
found, which results in a nonfunctional truncated APC protein lacking the carboxyl 
terminus [53, 56]. Though Apc has many other functions other than controlling Wnt 
signaling, many of the functions of Apc, in the hematopoiesis system, is β-catenin 
dependent [57]. 
Besides regulating β-catenin levels, APC also controls cell migration, apoptosis, and 
chromosomal segregation during mitosis [58]. APC regulates cell migration through its 
interactions with microtubules, EB1, and IQGAP1 [58-67]. APC has also been 
associated in chromosome instability (CIN). Colorectal adenomas with mutated APC 
display aneuploidy [68-70]. Embryonic stem (ES) cells from APC/min mice, but not wild-
type ES cells, are more susceptible to chromosomal aberrations and aneuploidy, 
implicating APC in chromosomal segregation [71]. The role of APC in regulating 
apoptosis is still unclear and is likely to be tissue-dependent. APC can promote 
apoptosis by regulating Wnt target genes such as caspases or histone deacetylase 2 
(HDAC2) [58, 72-74].  
1.3 T cell development, maintenance and effector function 
1.3.1 Thymocyte development 
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T lymphocytes originate from hematopoietic stem cells and progenitor cells that migrate 
from the bone marrow to the thymus to generate a population of immature thymocytes 
[75-78]. These immature thymocytes do not express CD4, CD8, nor CD3, therefore are 
designated as double negative (DN) thymocytes. DN thymocytes can further 
subcategorized by their expression of CD25 and CD44: DN1 (CD44+CD25-), DN2 
(CD44+CD25+), DN3 (CD44-CD25+), and DN4 (CD44-CD25-) [75, 79-81]. Once a TCR β 
chain is successfully assembled [82], DN thymocytes will transition to double positive 
(DP) thymocytes.  DP thymocytes undergo positive selection and negative selection and 
finally mature into SP CD4 or CD8 thymocytes [82-90]. Although, it has been shown that 
SP undergoes further maturation, the ultimate cellular or molecular factors involved in 
the final stage thymic maturation before thymic egress is largely unknown. 
Once functionally mature, thymocytes exit the thymus to the peripheral lymphoid 
organs: the spleen and lymph nodes.  This process ensures the maintenance of the 
peripheral T cell pool. However, the pathways that control thymic egress has not been 
fully defined. One possible transcriptional regulator of thymic egress is Krüppel-like 
factor 2 or KLF2, which licenses functionally mature thymocytes (CD24loQa-2+) to 
emigrate out of the thymus by regulating expression levels of sphingosine-1-phosphate 
(S1P) receptor S1P1, CD62L, and β7 integrin [91-94].  CD69 also regulates thymic 
emigration by negatively regulating the expression of S1P1 [95, 96]. 
Upon reaching the peripheral lymphoid organs, naïve T cells stay largely quiescent until 
they encounter their specific antigen and initiate immune response, as diagrammed in 
Fig. 1.2.  
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1.3.2 Naïve T cell maintenance 
In the periphery, naïve T cells are held in quiescence until they interact with their 
cognate antigen/MHC complex presented by an antigen presenting cell (APC). This 
interaction causes the naïve T cell to become activated and differentiate into an effector 
T cells. Quiescence is not a passive progress, rather, naïve T cell quiescence is 
enforced by several candidate pathways including mammalian target of rapamycin 
Figure 1.2. T cell: a life story. T cell development begins in the thymus as DN cells that do not 
express CD4 or CD8. These DN cells are subcategorized by their expression of CD44 and CD25 
into DN1-4. After a successful β-chain rearrangement, DN cell transition in DP cells that express 
both CD4 and CD8. DP, then, transition into SP cells that express either CD4 or CD8. Once 
functionally mature, SP thymocytes exit out of the thymus entering the peripheral lymphoid 
organs as naïve T cells with high expression of an adhesion molecule, CD62L. Naïve T cells are 
held in a quiescent stage until an encounter with its cognate antigen, activating the cells to 
differentiate further into either central memory cells or effector memory cells that express high 
levels of CD44. Central memory cells can be distinguished from effector memory cells by their 
expression of CD62L. Adapted from [2].  
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(mTOR) [97, 98], forkhead box family members [99-101], and Schlafen-2 (Slfn2eka) 
[102]. Genetic manipulations of these pathways lead to a loss of peripheral T cells and 
an increase of spontaneous activation and differentiation.  
T cells deficient in the Fox family members have diminished peripheral T cell numbers, 
suggesting their importance in naïve T cell maintenance. Foxo1 has been shown to be 
important in expressing IL-7R. IL-7 signaling is essential for naïve T cell survival [100]. 
Foxp1 deletion leads to increased IL-7R(α) expression, which then sensitizes T cells to 
IL-7-driven proliferation and differentiation [99]. However, it is still unknown how these 
Fox members together interact synergistically to coordinate the expression IL-7R(α). 
Collectively, the Fox family members allow for naïve T cells to finely tune the response 
to IL-7 signaling.  
Mice with T-lineage-specific deletion of tuberous sclerosis complex 1 (Tsc1), which 
leads to constitutive mTOR activation, also have a reduction of peripheral T cells that is 
associated with increased apoptosis; a phenotype that could be rescued through forced 
Bcl-2 expression [98]. T cells that are deficient in Tsc1 have increased expression of 
positive regulators of the cell cycle, suggesting that mTOR inhibition restrains naïve T 
cell proliferation [97, 98]. These studies have provided very convincing evidence 
supporting the role of mTOR in the maintenance of naïve T cell quiescence, but it is still 
unclear what stimulates TSC1 to inhibit mTOR signaling so that naïve T cell quiescence 
can be held. In this study, we studied the functions of the gene Apc, a possible 
upstream regulator of mTOR signaling, in the maintenance of naïve T cells. Previously, 
it has been shown that APC can enhance the activity of GSK3β, which in turn, 
phosphorylates TSC2, thus inhibiting mTOR activation [103]. It is also known that β-
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catenin becomes stabilized and translocates into the nucleus rapidly after TCR signaling 
though a phosphatidylinositol 3- kinase (PI3K) and phospholipase C (PCK) dependent 
manner [104]. By removing a known regulator of β-catenin via conditional deletion of 
Apc, we can examine the ectopic activation of Wnt and its effects on the regulation of 
mTOR activation and resulting naïve T cell maintenance, thereby connecting TCR 
signaling to TSC stimulation.  
1.3.3 Effector Cell differentiation   
After activation, CD4+ T cells will expand and differentiate into distinct effector subsets: 
T helper (Th) cells, which are defined by their cytokines and transcription factors, as 
diagramed in Fig. 1.3. These subsets include: Th1, Th2, Th17, and T helper cells [105, 
106]. Th1 cells are delineated by their production of interferon-ϒ (IFN-ϒ) and the 
expression of the transcription factor, T-bet. Th1 cell cytokines activate macrophages 
and defend against intracellular bacteria and some viruses [105, 106]. GATA-3 
expressing Th2 cells produce Il-4, Il-13, and Il-5. Th2 cells activate eosinophils, aid B 
cells in antibody production, and mount an immune response against helmiths [105, 
107, 108]. The transcription factor, FoxP3, is expressed by T regulatory (Treg) cells that 
produce immunosuppressive cytokines, such as TGFβ and Il-10[105, 107]. RAR-related 
orphan receptor gamma (RORγ) expressing Th17 cells produce Il-17A, IL-17F, and IL-
22. Th17 cells are important in defense against some extracellular bacteria and fungi, 
and have been implicated with the pathogenesis of many autoimmune diseases [105, 
109, 110]. Though the master transcription factors for each of these effector CD4 T cells 
have been well defined, when considering the complexity of inflammation, the system-
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level cellular responses composed of multiple signaling pathways and how each of 
these interact to influence effector T cell differentiation is still unclear. 
 
  
 
 
1.4 Role of Wnt signaling in T cell biology 
1.4.1 Wnt in thymocyte development 
Many aspects of T cell biology: development, activation, and differentiation, are 
regulated by Wnt signaling. The importance of Wnt signaling in T cell development was 
Figure 1.3 T helper cell differentiation. Naïve CD4 T cells will expand and differentiate into different T 
helper subsets: Th1, Th2, Th17, and Tregs. Th1 express the transcription factor T-bet and will produce 
IFNϒ. Th2 are defined by expression of GATA-3 and produce IL-4 and IL-13. Th17 express the 
transcription factor RORϒt and produce the cytokines IL-17A and IL-17F. Finally, T regulatory cells express 
FOXP3 and produce IL-10 and TGF-β. Adapted [1]. 
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first illustrated with studies using either TCF1 or LEF1 deficient mice. Two different 
knockout mice for TCF1 were developed: deletion of exon 5 or exon 7 [111]. A deletion 
of exon 5 resulted in a truncated TCF protein that was still functional, therefore only 
caused a minor decrease in thymic cellularity. With an exon 7 deletion of TCF1, TCF-1 
no longer has DNA binding activities, consequently nullifying TCF-1 transcriptional 
activity [111].  With an exon 7 deletion of TCF-1, thymocyte development was severely 
impacted: thymic cellularity was drastically reduced resulting from an age-dependent 
blockage at the immature SP (ISP) to DP transition. In addition to the developmental 
blockade at the ISP to DP transition, TCF1 exon 7 deletion caused a reduction of DN2 
thru DN4 cells due to decreased cell proliferation [111]. Surprisingly, LEF1 deficiency 
does not affect T cell development. A deletion of both LEF1 and TCF1, using an exon 5 
deletion of TCF1, resulted in a complete blockage in thymocyte development at the ISP 
stage of development, suggesting a redundant role for LEF1 and TCF1 in thymocyte 
development [112].  
Despite these results demonstrating the importance of TCF-1/LEF-1 in thymocyte 
development, the dependence of canonical Wnt signaling mediating these defects is 
disputed. Conditionally deleting β-catenin using a T cell specific promoter, Lck-cre, 
resulted in a partial developmental blockages at the β-selection checkpoint of thymocyte 
development  [113]. However, this β-catenin conditional deletion was not as striking as 
the TCF-1 exon 7 deletion, suggesting that some of the phenotypes seen in TCF-1 exon 
7 deficient thymocytes may be the result of β-catenin independent functions. To add to 
the debate over the role of canonical Wnt signaling in thymocyte development, mice 
with a conditional deletion of β-catenin in the hematopoietic stem cell compartment did 
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not result in any phenotype in lymphopoeisis [12]. To exclude the possibility that β-
catenin’s homologue, ϒ-catenin, was compensating for the loss of β-catenin, double 
knockouts of both β-catenin and ϒ-catenin were made. However, no phenotype was 
observed, leading the authors to conclude that Wnt signaling is dispensable for 
hematopoiesis and lymphopoeisis [114, 115]. Furthermore, in a mouse model that 
overexpressed ICAT, a molecule that inhibits interactions between TCF-1 and β-
catenin, was unable to recapitulate the extreme phenotype as seen TCF-1 exon 7 
deleted thymocytes. ICAT overexpression, when expressed early in thymocyte 
development, did cause a developmental blockage at the DP stage, but when 
introduced later, did not inhibit SP thymocyte development [116]. Though TCF-1 has 
been shown to play a role in regulating thymocyte development, it remains to be 
demonstrated whether this role is dependent on canonical Wnt signaling. 
In studies where gain-of-function mutations were made, the effects of ectopic Wnt 
activation has also created inconsistent conclusions. Loss of APC (Wnt activation) 
caused a developmental blockage at the DN3 to DN4 transition [117]. Likewise, knockin 
non-degradable β-catenin (deletion of exon 3) also affected thymopoiesis, where DP 
thymocyte development continued in the absence of pre-TCR signaling [118]. However, 
another group showed that stabilized β-catenin did not affect thymocyte development in 
young mice (6-8 weeks old). Instead, an overexpression of β-catenin accelerated thymic 
involution, as 3 month old mice thymic cellularity were drastically reduced [119]. With 
these conflicting studies, additional investigations are necessary to further delineate the 
role of Wnt in thymocyte development. In our study, we clarified the role of Wnt in 
thymocyte development by ectopically activating Wnt signaling via a conditional deletion 
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of APC through both Lck-cre and CD4-cre. Neither Lck-cre nor CD4-cre resulted in any 
thymocyte development blockade, but Lck-cre accelerated thymic involution as seen in 
a previous study. Thus, we demonstrated that Wnt activation is not sufficient to affect 
thymocyte development. 
1.4.2 Wnt in T cell differentiation  
Studies investigating the role of Wnt on T regulatory cell (Treg) functions have 
conflicting results. Enhancing Wnt signaling by a retroviral transduced β-catenin in 
CD4+CD25+ T cells improved Treg suppression of a model of inflammatory bowel 
disease that is induced by naïve T cell transfer. Stabilized β-catenin upregulated 
expression of Bcl-XL [120] thereby improving Treg survival; implying an 
immunosuppressive role for Wnt activation. Conversely, Tregs with an exon 3 deletion 
of β-catenin (constitutively active Wnt) could not suppress inflammatory bowel disease 
[121]. Another study found that inhibition of Wnt via a deletion of TCF-1 yielded Tregs 
with improved suppression of inflammation, though this result may be due to canonical 
Wnt-independent functions of TCF-1 [122]. Together, these studies have shown that 
Wnt’s role in Treg function is still quite unclear. 
The roles of canonical Wnt signaling in effector/memory T cell responses are also 
controversial. Activation of Wnt signaling, through in vitro addition of GSK-3β inhibitors, 
favors the production of memory CD8 T cells rather than the terminally differentiated 
effector T cells [123]. However, this effect was not observed by another study which 
showed that addition of GSK3β inhibitors did not affect CD8 T cell differentiation nor did 
increased Wnt signaling generate CD8 memory stem cells. Most importantly, deletion of 
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β-catenin did not perturb CD8 memory stem cells after priming [124].  The opposing 
data in these two reports remains to be reconciled.  
The role of Wnt in the maintenance of memory CD8 T cells has also been studied via 
exon 7 deletion of TCF-1. Studies have shown that TCF-1, though a β-catenin-
dependent regulation of eomes, increases the expression of IL-2βR, therefore 
maintaining CD8 T cell responsiveness to IL-15 [125]. In a conflicting study, Prlic et al. 
demonstrated that Wnt is dispensable for T effector cell function as mice with β-catenin-
deficient T cells mounted a normal immune response to bacteria, as evidenced by   
comparable bacterial clearance, expression of CD62L and KLRG1, and no observed 
increase in memory CD8 T cells [126]. Perhaps this discrepancy in results is caused by 
the use of TCF-1 deletion rather than β-catenin deletions, thus the phenotypes seen in 
TCF-1 deficiency may not be the cause of Wnt activation, but its Wnt-independent roles.  
1.5 Lymphopenia and autoimmune disease 
The number of T cells in the peripheral lymphoid organs are relatively constant in an 
adult animal. T cell homeostasis is achieved by different mechanisms at different stages 
of life.  In healthy young adults, the size of the peripheral T cell pool is dependent on 
seeding via thymopoiesis. As animals age, the thymus atrophies, thus shifts the 
maintenance of the peripheral T cell pool from the thymus to a process called 
homeostatic proliferation (HP). HP also occurs during the perinatal period when the 
number of T cells produced by the thymus is low (lymphopenic) compared with the 
space in the peripheral lymphoid organs [127]. 
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HP occurs when T cells rapidly proliferate in response to lymphopenia. HP is distinctly 
different from the normal expansion of T cells due to antigen interactions [128]. During 
HP, T cells are allowed to proliferate in response to low affinity antigens and self-
antigens. More importantly, this response is not toward a single foreign antigen, but is a 
polyclonal response. This expansion of T cells also allows low-affinity T cells that 
normally would not have been activated to acquire effector traits: expressing CD44, 
Ly6c and producing IFNγ [129-133]. During HP, T cells are allowed to expand in 
response to self-antigen, thus skewing the TCR repertoire toward self-reactivity [134-
137]. This HP-driven self-reactivity is observed in H-2M mice. H-2M mice express CLIP 
peptide both in the thymus and in the periphery. In a non-lymphopenic host, CD4+ T 
cells will be positively selected for while in the thymus, therefore peripheral T cells will 
not proliferate in the presence of the CLIP peptide. In contrast, lymphopenic H-2M mice 
have CD4+ T cells expanding due to recognition of the CLIP peptide. In the context of 
lymphopenia, T cell proliferation has the ability to proliferate to self-antigen, thus 
skewing the TCR repertoire toward autoimmune disease [138].  
The link between lymphopenia and autoimmune disease has been demonstrated 
through mouse models of inflammatory bowel disease. RAG-1 deficient mice, which 
lack both B and T cells, will develop inflammatory bowel disease with the transfer of 
small numbers of naïve CD4+ T cells [139, 140]. More importantly, disease severity is 
correlated to the ability of these T cells to HP in vivo [139, 141]. Artificially inducing 
lymphopenia by neonatal thymectomies can also induce autoimmunity, however, it 
should be noted that severity and incidence of disease is dependent on the strain of 
mouse [142].  Thus, lymphopenia provides an ideal condition for the development of 
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autoimmune disease. However, as seen in the neonatal thymectomies, lymphopenia is 
not always sufficient in inducing autoimmunity. 
Many human autoimmune diseases are associated with lymphopenia including: 
Sjogren’s disease, rheumatoid arthritis, systemic lupus erythematosus (SLE), and 
Crohn’s disease [134, 143-147]. Thymectomized myasthenia gravis patients that 
present with mild lymphopenia are predisposed to the development of SLE [148]. 
Rheumatoid arthritis patients, who are also lymphopenic, present with decreased TCR 
diversity. This has been attributed to HP because HP selects for T cell clones that have 
high affinity to self, thus skewing T cell repertoire toward self [149-151]. In addition to T 
cell repertoire skewing, T cells from RA patients acquire effector characteristics, defined 
by lymphopenia-driven HP [152-154]. Diabetic patients also present with aberrant T cell 
homeostasis. Many at-risk and newly diagnosed patients have increased percentages 
of activated T cells, but reduced numbers of peripheral T cells [155-157]. Murine studies 
have also shown a link between lymphopenia and autoimmunity. For instance, 
nonobese diabetic (NOD) mice were observed to have slightly lower numbers of T cells. 
The resulting population of T cells are activated and will eventually destroy β-cells 
causing diabetes. However, infusing the NOD mice with more T cells, the development 
of autoimmune diabetes can be delayed. Lymphopenia was not the only factor in in the 
development of diabetes. The investigators bred the NOD to a different background, 
Idd3.NOD mice, but did not develop autoimmune diabetes, though these mice still were 
lymphopenia. In addition to lymphopenia, NOD mice produced more IL-21 allowing for 
increased HP. This demonstrates that lymphopenia is not sufficient to generate 
autoimmunity, but a cofactor to autoimmunity [158].  
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Cell extrinsic factors, such as regulatory T cells, have also been hypothesized to play a 
role in suppressing lymphopenia-induced autoimmune disease. The addition of 
CD4+CD25+ Tregs can alleviate autoimmunity in thymectomized mice [142]. Still, 
depletion of Tregs in lymphopenic hosts is not always sufficient in inducing autoimmune 
disease [159]. When both naïve and Tregs are transferred into a lymphopenic host, the 
transferred Tregs do little to inhibit the proliferation of naïve T cells. It is possible that 
Tregs are not involved in the inhibition of HP in response to lymphopenia, but instead, 
are crucial in the suppression of the immune response in a much later stage of disease 
[160, 161]. 
Together, these studies have shown that lymphopenia-induced HP is a co-factor in 
autoimmune disease. However, the intrinsic T cell programs that are involved in the 
process are still unclear. Mutations in several genes lead to lymphopenia, such as 
deletions of Tsc1 [97, 98] and Klf2 [91, 92], but were insufficient to cause autoimmune 
diseases. Components of Wnt signaling have been associated with autoimmune 
disease. SNPs in the TCF-4 promoter region are associated with increased incidence of 
ileal Crohn’s disease due to impaired paneth cell production of α-defensins [162, 163]. 
The co-receptor for Wnt signaling, LPR6, has also been shown to be functionally 
mutated in early onset ileal Crohn’s disease patients, damaging the regenerative 
potential of the intestinal crypts [164]. TCF7 SNPs result in β-cell dysfunction causing 
an increased risk in type II diabetes [165]. And finally, increased Wnt activation in the 
synovial fluid of rheumatoid arthritis patients is associated with increased severity of 
disease [166, 167]. Many of these studies are either related to dysfunction of tissue 
differentiation/remodeling, but Wnt activation T cells as a contributing factor for 
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autoimmunity has not been studied. Our study has implicated ectopic Wnt activation in 
autoimmune disease through a single T cell specific deletion that is sufficient to cause 
lymphopenia-driven autoimmune disease.  
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Chapter 2 
 
On the Role of APC in early T cell development 
 
2.1 Abstract  
 
Wnt signaling has been found to regulate T lymphocyte development. It has been 
demonstrated that Wnt signaling plays a central role in early T cell development from 
studies where exon 7 deletion of TCF-1 inhibited thymocyte production. However, other 
studies dispute whether this developmental defect is a reflection of canonical Wnt 
signaling or of TCF-1-Wnt independent signaling.  In this study, we further elucidated 
the role of Wnt signaling in thymocyte development by deleting a negative regulator of 
Wnt, Adenomatous polyposis coli (APC) using two lines of Cre-driver with minor 
differences in the time of Apc gene deletion within the DN3 stage of thymocyte 
development. Ectopic activation of Wnt signaling was observed in DN4 thymocytes. 
While Apc deletion ectopically activated Wnt signaling by increasing nuclear β-catenin 
and increased expression of Wnt target genes, such as cMyc and Cd44 in mature 
thymocytes, the cellularity and major subset distribution among the thymocytes were not 
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affected.  Our data demonstrated that ectopic activation of Wnt signaling starting at DN4 
does not interfere with thymocyte development. 
2.2 Introduction 
Wnt signaling is an evolutionarily conserved pathway that is involved in cell 
differentiation, cell polarity, and maintenance of stem cell populations. Wnt signaling is 
initiated with the binding of Wnt proteins, cysteine-rich glycoproteins, to two receptors: 
Frizzled (FZ) and low-density lipoprotein receptor-related proteins (LRP) [3, 32, 33, 
168].  As a result, Dishevelled, Dvl, inactives glycogen synthase kinase 3β (GSK3β). 
This allows for the accumulation and subsequent translocation of β-catenin into the 
nucleus, where it binds to members of the TCF/LEF family of transcription factors 
thereby activating Wnt target genes [11, 13, 16, 39-41]. In the absence of Wnt proteins, 
levels of β-catenin are regulated by the “destruction complex” composed of APC, GSK-
3β, and Axin [19]. Identification of these key components provides us with ample 
opportunities to genetically manipulate the strength of Wnt signaling.     
T lymphocyte development is among the best characterized among mammal tissues.  
From the bone marrow, progenitor cells migrate to the thymus to generate a population 
of immature thymocytes [75-78]. These immature thymocytes are designated as double 
negative (DN) thymocytes, because they do not express CD4 and CD8. DN (DN 1-4) 
thymocytes can further subdivided by their expression of CD25 and CD44 [75, 79-81]. 
DN thymocytes, mature into double positive (DP) thymocytes after a successful TCRβ 
chain has been assembled.  DP thymocytes undergo positive selection and negative 
selection and finally develop into SP CD4 or CD8 thymoyctes [82-90]. 
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Studies using TCF-1- and LEF-1-deficient mice suggest that Wnt signaling plays a 
critical role in thymocyte development [111, 112, 169].  TCF-1 was found to be 
important in driving the proliferation of DN2, DN4, and ISP thymocytes [111]. Ioannidis 
et al. demonstrated that this blockage can be recapitulated by deleting the β-catenin 
binding domain in TCF-1 [170], thus tying the defects of TCF-1 deficient thymocytes to 
the lack of Wnt signaling [170]. In support of this notion, constitutively activating Wnt, by 
ectopically expressing a non-degradable β-catenin at the DN3 stage, results in lack of 
the CD3-TCR complex on DP thymocytes. Ectopic Wnt activation in DN3 thymocytes 
bypasses pre-TCR signaling, and allows for the differentiation of DP thymocytes without 
surface expression of TCR-CD3 [171]. Ioannidis et al. also showed that these DP cells 
were also more resistant to apoptosis through the expression of BCL-XL [170]. The 
importance of Wnt signaling was further confirmed in fetal thymi of Wnt1-/-Wnt4-/- mice, 
where the lack of Wnt signaling affected thymocyte proliferation at the DN and ISP 
stages of development [172].  
Directly deleting β-catenin, via a CRE-LOXP system controlled by the Lck promoter, 
leads to a developmental blockage at the DN3 stage, specifically at the TCRβ chain 
selection checkpoint. However, a TCF-1 deficiency did not cause a similar phenotype. 
Furthermore, Gounari et al. reported that deletion of Apc, using Lck-Cre, disturbs 
thymocyte development [117].   Despite of these reports, several lines of evidence 
dispute a role for Wnt signaling in thymocyte development. For example, mice with a 
broad β-catenin deletion via Mx-cre had normal lymphopoiesis [12]. It was postulated 
that the difference between this study and the study using β-catenin, via a Cre-LoxP 
system controlled by the Lck promoter, was due to either the differences between the 
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Cre drivers or the possibility of γ-catenin compensating for the loss of β-catenin. 
However, deletion of both β-catenin via MX-Cre and γ-catenin null allele also had no 
effect on lymphopoiesis [114, 115]. Overall, these studies illustrate that the role of Wnt 
signaling and its regulators in thymocyte development are not fully understood. In this 
study, we further investigated the role of Wnt signaling in thymocyte development by 
using an Apc conditional allele that has loxP sites inserted into introns 13 and 14 of the 
endogenous Apc gene under the control of both CD4-Cre and Lck-Cre transgene. We 
found that APC is not essential for later stages of thymocyte development. 
2.3 Materials and Methods 
Mice 
 CD45.1 C57BL/6 mice were obtained from Charles River Laboratories, through a 
contract with the National Cancer Institute.  Mice with homozygous knockin of the floxed 
Apc [173] and transgenic mice expressing the Cre recombinase, under the control of 
either the proximal Lck promoter [174] or CD4 promoter [175], were obtained from 
Jackson Laboratories (Maine, USA).   All mice used in this study have been 
backcrossed to C57BL/6 background for at least 10 generations. These strains were 
maintained in our animal facilities under pathogen-free conditions. All experiments were 
performed in accordance with the guidelines of the Institutional Animal Care and Use 
Committees of the University of Michigan and the Children’s National Medical Center.  
Flow cytometric analysis 
 Mice were sacrificed at 6-8 weeks of age.  Thymus and spleen tissues were 
homogenized to generate a single-cell suspension.  Cells were stained at 4ᵒC for 20 
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minutes in phosphate-buffered saline with 2% FBS with the following antibodies from 
BD Bioscience (1:200): CD4 (RM4-5, 25-0042-82), CD8 (SK-1, 8066-0087-120), B220 
(HIS24, 25-0460-82), CD44 (IM7, 12-0441-83), CD62L (MEL-14, 17-0621-83), CD24 
(30-F1, 12-0241-83), CD69 (H1.2F3, 12-0691-83), CCR7 (4B12, 17-1971-82), beta 7 
integrin (FIB205, 12-5867-42), β-catenin (15B8, 50-2567-42), δϒ TCR (UC7-13D5, 11-
5811) and CD25 (PC61.5, 17-0251-82).  Samples were analyzed by using a BD LSR II 
Flow Cytometer. 
For the co-localization experiment, splenocytes were stained for CD3 (145-2C11, 12-
0031) and permeabilized using the BD fix/perm kit™ (554714). β-catenin was stained 
overnight (1:100) (15B8, 50-2567-42). DRAQ5 (ebioscience, 65-0880-92) was added 
(1:10,000) right before analysis using an Amnis Imaging Flow Cytometry. Analysis was 
carried out using IDEAS® software. Calculations were made by following IDEAS® 
software’s wizard. 
Statistics 
 Data was analyzed using 2-tailed unpaired Student’s t-tests.  All statistics were 
performed using GraphPad Prism, version 5 (GraphPad Software, San Diego, CA). 
*P<0.05, **P<0.01, ***P<0.001. 
 
2.4 Results 
2.4.1 Deletion of exon 14 floxed Apc by CD4-Cre results in loss of APC function 
and β-catenin accumulation/translocation  
23 
 
In order to study role of Apc in T cells, we used CD4-Cre to delete Apc and used a more 
commonly known Apc conditional allele that has loxP sites inserted into introns 13 and 
14 of the endogenous Apc gene (Apcfl)[173].  These mice were labeled as cKO, while 
their Cre- littermates were used as a control and labeled as Ctrl. Based on the known 
specificity of the Cre promoter, Apcfl/fl;CD4-Cre+ mice should have a frameshift mutation 
at codon 580 and a truncated APC polypeptide. Before assessing the role of Apc in 
thymocyte development, we needed to confirm Apc deletion among thymocytes. CD4-
cre expression should begin the DN3 stage (CD4-CD8-CD25+CD44-) of thymocyte 
development, thus we FACS-sorted CD4-CD8- (DN) thymocytes based on their 
expression of CD4, CD8, CD44, and CD25.  Using polymerase chain reaction (PCR) 
that yielded differently sized products from floxed (fl) and deleted (del) Apc alleles, we 
determined the kinetics of Apc deletion in developing DN thymocytes. As expected, no 
deletion was observed in DN1-4 of the Ctrl mice.  In the cKO thymocytes, nearly equal 
amounts of fl and del alleles were observed in DN3.  By DN4, most products were 
derived from the del allele (Fig. 2.1a).  Thus, the Apc deletion began at the DN3 stage 
and was largely completed at the CD4-CD8-CD25-CD44- DN4 stage in the cKO mice.   
Since the primary function of the Apc protein is to mediate the destruction of -catenin, 
we used intracellular accumulation of the protein as the primary readout for functional 
Apc inactivation throughout thymocyte development.  As shown in Fig. 2.1b, despite a 
nearly 50% deletion of the Apc gene, no increase of intracellular -catenin was 
observed in the DN3 stage.  Likewise, although the Apc deletion was nearly complete in 
the DN4 stage, only a small subset showed functional inactivation of the Apc protein.  
However, significant accumulation of -catenin was observed from the bulk of 
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CD4+CD8+ (DP), CD4+CD8- (CD4 SP), and CD4-CD8+ (CD8 SP) thymocytes.  The 
delayed functional inactivation of the Apc protein in relation to the gene deletion is likely 
due to residual Apc protein and/or mRNA. Regardless, the robust activation of Wnt 
signaling from the DP stage allowed us to assess the function of ectopic activation of 
Wnt in T cell development and function starting at the DP stage.   
To investigate whether β-catenin accumulation is adequate for its translocation into the 
nucleus, we stained for CD3+ and β-catenin+ splenocytes of both ctrl and cKO mice. 
Using Aminis Imaging flow cytometry, we evaluated the levels of β-catenin in the 
nucleus marked with DRAQ5. We first gated on the CD3+ and β-catenin+ populations.  
As seen in Fig 2.1c, much like cKO thymocytes, splenic cKO had as much as 80% 
accumulation of β-catenin. In order to determine whether this accumulation results in 
translocation of β-catenin into the nucleus, we gated on the population that were 
observed to have β-catenin localizing with the nuclear stain, DRAQ5. Fig 1c clearly 
shows in over 50% of the case localizes in the nucleus, thus demonstrating that without 
APC, β-catenin will stabilization and translocate into the nucleus thereby ectopically 
activating Wnt signaling. Through sorting of DN populations, we showed that APC is 
deleted, on the DNA level, starting at the DN3 stage. Intracellular staining showed that 
this deletion of APC does functionally result in accumulation of β-catenin, and via 
Aminis imaging, we concluded that this accumulation results in the translocation of β-
catenin, which thereby ectopically activating Wnt signaling.  
2.4.2 Deletion of exon 14 floxed Apc by CD4-Cre does not grossly disturb 
thymocyte development 
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One method to evaluate thymocyte development is to assess thymic cellularity, which 
gives a general indication of the production of thymocytes. As shown in Fig. 2a, Ctrl and 
cKO thymi had comparable cellularity. To more closely assess thymocyte development, 
we stained thymocytes for CD4, CD8, CD25, and CD44, allowing us to investigate the 
DN, DP, and SP populations. Distribution of CD4 and CD8 markers among thymocytes 
revealed no gross abnormality in thymocyte development as the % (Fig. 2b) and 
numbers (Fig. 2.2c) of DP, CD4 SP, and CD8 SP thymocytes were similar. As expected 
from the largely normal catenin levels in cKO DN thymocytes, the frequency (Fig. 2d) 
and number (Fig. 2.2e) of double negative cells (CD4-CD8-, DN) were also comparable 
throughout stages 1-4. Thus, the deletion of Apc that began at the DN3 stage did not 
affect thymocyte development.  However, we did observe an increase in apoptosis of 
Apc- deficient thymocytes (Fig 2.3a), although apoptosis was more pronounced in 
peripheral T cells (Fig 2.3b). 
The differences observed between our results and those in a previous study [117] was 
not due to a subtle difference between the Lck-Cre used in the previous study and the 
CD4-Cre used here. In our hands, both CD4-Cre and Lck-cre had largely normal 
thymocyte development (Fig 2.4). However, the modest but statistically significant 
reduction in cellularity and decrease in SP thymocytes in Lck-Cre mice suggests that 
even minor differences in timing of gene deletion can affect the outcomes.   
One potential phenotypic difference between Lck-Cre and CD4-Cre is in the expression 
of CD44 a known Wnt target gene. In the periphery, both CD8 and CD4 T cells from 
Lck-Cre and CD4-Cre upregulated CD44 at much higher levels than in the Ctrl mice. 
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However, thymocytes show a different pattern, where SP CD4 and CD8 thymocytes in 
CD4-Cre mice express much higher levels of CD44, while Lck-Cre levels of CD44, 
though higher, appears much more like Ctrl mice.  In addition, we observed a loss of 
thymic cellularity and an apparent increase of DN thymocytes in older CD4-Cre-induced 
cKO mice that became moribund (Fig. 2.4c and 2.4d).  This raised the intriguing 
possibility that abnormal thymocyte development may be secondary effect of overall 
immune activation in the mice, as reported by Martin et al. [176].  Overall, our data 
demonstrates that Wnt signaling starting at DN4 did not directly disturb normal T cell 
development in healthy young mice.  This normal T cell development allowed us to 
study the function of Wnt signaling after T cell maturation. 
Though thymcyocyte development looked relatively normal at 6-8 weeks of age, when 
the Lck-cre are aged, the thymic mass begins to decrease drastically (Fig 2.5). This is 
indicative of thymic involution, which has also been previously reported in mice with 
stabilized β-catenin, also under the control of Lck-cre [119].   
Since  T cells development divert from that of  T cells prior to DN3, one would not 
expect significant effect of CD4-Cre-induced Apc deletion on the fate of  T cells.  As 
shown in Fig. 6, the numbers of gd T cells in the thymus and spleen were comparable 
between ctrl and cKO mice. 
2.5 Discussion 
In this study, we have demonstrated that Apc is not essential in later stages of 
thymocyte development. Ablation of Apc beginning from the late DN3 to DN4 stage  
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perturbs neither frequencies nor numbers of thymocyte subsets (DN, DP, CD4 SP, nor 
CD8 SP). We showed that the lack of developmental blockages were not due to an 
inefficient deletion of Apc, as seen by the efficient deletion at the DNA level of 
thymocytes at the DN4 stage. Furthermore, this deletion of Apc does effectively active 
Wnt signaling as see by the accumulation of β-catenin and nuclear translocation of β-
catenin into the nucleus.  
A previous report showed a dramatic developmental arrest of thymocytes at the DN4 
stage by an Apc deletion [117]. This phenotype was not recapitulated when the 
interaction between -catenin and Apc was inactivated by deletion of the Apc-binding 
domain on -catenin [171]. The reason for the delayed activation of Wnt signaling is 
unknown, as both the Cre-driver and the Apcfl differed in these studies. The previous 
study found -catenin increased in most of the cells from the DN3 stage and on, while 
our study observed an increase in only a small fraction of DN4 and all of the DP and SP 
thymocytes. The delayed functional inactivation of Apc in our model resulted in normal 
thymocyte development.  Since the CD4-Cre is activated later than the Lck-Cre in DN 
populations [177], we crossed the Apcfl allele with the Lck-Cre to rule out this possibility.  
We also found largely normal thymocyte development and severe lymphopenia when 
the Lck-Cre was used. We did not, however, assess the deletion efficiency or deletion 
timing of the Lck-cre mice. It is possible that in our hands, Lck-cre did not efficiently 
delete Apc as the previous study or the deletion occurred later than what is expected in 
the literature. 
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In our hands, a deletion controlled by Lck-cre appears to have caused accelerated 
thymic atrophy, a phenotype also similar to a study using an exon 3 deletion of β-
catenin (nondegradable form of β-catenin), though the role of Wnt signaling in thymic 
involution is still undefined [119]. Although subtle differences exist between the two: 
Lck-Cre- and CD4-Cre-induced cKO, these differences are not sufficient to account for 
the dramatic discrepancy between our study and the earlier work [117].  One 
explanation could be due to the use of different Apcfl alleles rather than different Cre-
drivers.  Finally, since activation of T-cells in the periphery can cause loss of thymocytes 
[176], the possibility that activation of T cells in the periphery may account for a part of 
the previously described phenotype [117] remains to be excluded. 
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Fig 2.1.  Deletion of exon 14 floxed Apc by CD4-Cre results in loss of APC function and 
β-catenin accumulation/translocation. 
a. Deletion efficiency of cKO.  6-8 week old DN thymocytes were sorted using CD44 and CD25 
expression.  Using PCR, deletion was detected.  Wt allele: 314 bp, deletion: 258 bp.  
Experiment was repeated twice. b. Expression of intracellular β-catenin in 6-8 week old ctrl or 
cKO.  Stained for CD4, CD8, CD25, and CD44.  Gated on DN population.  n=9, per group.  c. 
Splenocytes were stained for CD3, β-catenin, and DRAQ-5. Cells were gated on CD3+ cells. 
Images were taken using Amis imaging flow cytometry and analysis was done using IDEAS 
software. 
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Fig. 2.2.  Normal thymocyte develop in the cKO mice. a. Thymic cellularity of 6-8 week old Cre- 
controls (open circles) and APC cKO (closed circles) mice, n=15.  b. Representative profiles of 
thymi from ctrl or cKO. c. Absolute numbers of DP, SP CD8 and CD4 thymi. n=9.  d. 
Representative profiles of DN populations of control or APC cKO. e. Absolute number of DN 
populations from 6-8 week old ctrl or cKO mice. n=8. 
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Figure 2.3. Increased apoptosis in cKO T cells in the thymus (a) and spleen (b). Ctrl 
(open bars) and cKO (filled bars) n=3 per group  
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Figure 2.4 
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Fig. 2.4.  Subtle thymocyte developmental defects caused by Lck-Cre-driven deletion of 
the Apc exon 14 in 6-8 week old mice.  a. Thymic cellularity of Apcfl/fl;Lck-Cre- (Ctrl) and 
the Apcfl/fl;Lck-Cre+ (Lck-cKO) mice. n=8.  b. Thymocyte development based on 
distribution of CD4 and CD8 markers. Representative profiles are shown on the left, 
while summary data are presented on the right.  n=9. c. Thymocyte development based 
on distribution of CD44 and CD25 markers among the CD4-CD8- thymocytes. 
Representative profiles are shown on the left, while summarized data is presented on 
the right.  n=9. Note that the overall levels of CD44 are elevated among the DN4 
subsets in the Lck cKO thymocytes.  This is to be expected, as CD44 is a hallmark of 
Wnt signaling target gene. d. Summarized MFI expression, from one experiment, of 
CD44 in SP thymocytes and splenic T cells in Lck-cKO and CD-cKO. n=3. This 
experiment was repeated twice. 
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Figure 2.5 
 
 
 
 
 
Figure 2.5 
Thymic cellularities of 4-6 month old control (circles) or Lck-cre (squares).  Lck-cre or 
ctrl thymi were weighed at 4-6 months of age. 
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Figure 2.6 
 
 
 
 
 
 
Figure 2.6. Apc deletion by CD4-Cre does not cause alteration in  T cells lineages. 
Ctrl (open circles) and cKO (filled squares) thymocytes (a) and splenocytes (b) were 
stained with anti-TCR and anti-TCRδ complex mAbs.  The data is shown as the mean 
and SEM of %  T cells, summarized from two independent experiments involving 6 
mice at 6-8 weeks of ages in each group. 
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Chapter 3 
 
APC regulates naïve T cell survival via c-Myc-dependent mechanisms 
 
3.1 Abstract  
 
The role of Wnt in thymocyte development and antigen-driven T cell differentiation and 
maintenance of memory populations has been extensively studied. However, very little 
is known about the role Wnt plays in maintenance of naïve T cells in the absence of 
antigens. Using mice with T-lineage-specific deletion of the Apc gene starting at the 
DN3 stage, we observed a massive loss of naïve T cells with concurrent with the up-
regulation of cMyc expression and activation of the mTOR pathway. To address the role 
of cMyc activation in the loss of naïve cells, we created mice with a T-lineage-specific 
deletion of both Apc and cMyc.  We found that heterozygous and homozygous deletion 
of cMyc attenuated the loss of naïve Apc-deficient T cells.  However, cMyc deletion did 
not fully restore naïve T cell cellularity, raising the possibility that other pathways, such 
as Wnt-stimulated mTOR activation may also contribute to the loss of naïve T cells. 
  
3.2 Introduction 
Unless stimulated by their cognate antigen/MHC complex or homeostatic cues, naïve T 
cells proliferate at an exceptionally slow rate [178-180]. Under normal physiological 
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conditions, naïve T cell survival is dependent on both extrinsic factors and intrinsic 
programing.  
Extrinsic factors that control naïve T cell survival include MHC molecules, adhesion 
molecules, and cytokines. During thymic development, through a process of positive 
selection, thymocytes that are able to recognize self-peptide-MHC complexes are 
allowed to mature into naïve T cells [181]. The ability to recognize self-ligands extends 
to peripheral naïve T cells. Naïve T cells recognize of their specific MHC and self-
antigen for survival [178]. Cytokines also play a role in the maintenance of naïve T cells. 
In vitro culturing of naïve T cells with IL-4, IL-6, thymic stromal lymphopoietin, and IL-7 
rescued these T cells from apoptosis [182-184]. In vivo studies suggest Il-7 is the most 
dominant cytokine involved in naïve T cell survival. Blocking activity of IL-7 through 
monoclonal antibodies or deletions of IL-7R limited the survival and expansion of naïve 
T cells [182, 185, 186]. Signaling through IL-7R allows for survival via the regulation of 
B cell lymphoma 2 (BCL-2) family member proteins, including BCL-2 and MCL1 [187, 
188]. 
mTOR, FOXO family transcription factors, the transcriptional repressor Growth factor 
independent 1 (GFI1), KLF2, and Mst1 participate in cell intrinsic regulation of naïve T 
cell survival. Some control the responsiveness of naïve T cells to IL-7 signaling. 
Transcriptional regulation of IL-7R requires GFI1, in CD8 T cells, while FOXO (FOXO1 
and FOXO3) transcription factors are utilized by both CD8 and CD4 T cells [100, 101, 
189].  A different Fox factor, FOXP1, promotes the survival of naïve CD8 T cells through 
regulation of IL-7 signaling [99]. A deficiency of Schlafen-2 resulted in increased T cell 
apoptosis due to engagement of MHC/peptide complex or HP [102]. Recently our group 
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and others have shown that a deletion of a negative regulator of mTOR- tuberous 
sclerosis complex 1 (Tsc1) gene caused loss of naïve T cell quiescence and survival 
[97, 98]. However, it is still unclear what stimulates TSC1 to inhibit mTOR signaling. 
APC, being an upstream regulator of mTOR signaling, is a potential candidate as a 
regulator of naïve T cell survival. In this study, we investigated the role of Apc in naïve T 
cells. We showed in Chapter 2 that an Apc deletion does not affect thymocyte 
development, giving us a rare opportunity to examine the role of Apc in naïve T cells. 
Here, we show that Apc is an important cell intrinsic regulator of naïve T cell survival, in 
part via inhibition of a Wnt target gene, c-Myc. 
 
3.3 Materials and Methods 
Mice 
CD45.1 C57BL/6 mice were obtained from Charles River Laboratories, through a 
contract with the National Cancer Institute.  Mice with homozygous knockin of the floxed 
Apc [173] and transgenic mice expressing the Cre recombinase, under the control of 
either the proximal Lck promoter [174] or CD4 promoter [175], were obtained from 
Jackson Laboratories (Maine, USA). Mice with floxed cMyc locus [190] were kindly 
provided by Dr. De Alboran.  All mice used in this study have been backcrossed to 
C57BL/6 background for at least 10 generations. These strains were maintained in our 
animal facilities under pathogen-free conditions. All experiments were performed in 
accordance with the guidelines of the Institutional Animal Care and Use Committees of 
the University of Michigan and the Children’s National Medical Center.  
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Adoptive transfer of T cells 
Mature CD24-thymocytes were isolated by Dynal negative selection using biotinylated 
anti-CD24 mAb M1/69 (Ebioscience, 13-0242-85). Cells were labeled with 10 M CFSE 
and injected intravenously to CD45.1 recipients (1x106/mouse).  
Western blot analysis 
Tissues were lysed in a lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.5% NP-
40) supplemented with a protease inhibitor cocktail (Pierce, 78437).  Cell lysates were 
separated by SDS-PAGE and transferred to polyvinylidene fluoride membranes.  The 
membranes were incubated with anti-c-Myc (Abcam, AU016757, Ab39688,1:2000) and 
anti-actin (Abcam ACTN05, Ab1801, 1:5000). Either anti-rabbit or anti-mouse IgG 
horseradish peroxidase-linked antibody (Santa Cruz, 1:3000, SC-2054 and SC-2005 
respectively) was used as a secondary antibody.  A chemiluminescence kit (GE 
healthcare, RPN2133) was used to visualize blots.   
Flow cytometry 
Mice were sacrificed at 6-8 weeks of age.  Thymus and spleen tissues were 
homogenized to generate a single-cell suspension.  Cells were stained at 4ᵒC for 20 
minutes in phosphate-buffered saline with 2% FBS with the following antibodies from 
BD Bioscience (1:200): CD4 (RM4-5, 25-0042-82), CD8 (SK-1, 8066-0087-120), B220 
(HIS24, 25-0460-82), CD44 (IM7, 12-0441-83), CD62L (MEL-14, 17-0621-83), CD24 
(30-F1, 12-0241-83), CD69 (H1.2F3, 12-0691-83), CCR7 (4B12, 17-1971-82), beta 7 
integrin (FIB205, 12-5867-42), β-catenin (15B8, 50-2567-42), δϒ TCR (UC7-13D5, 11-
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5811) and CD25 (PC61.5, 17-0251-82).  Samples were analyzed by using a BD LSR II 
Flow Cytometer. 
Intrathymic injections 
 Five week old mice were anesthetized with isoflurane. A midline incision was 
used to expose the ribs. CFSE (10 l of a 1 mM solution, Invitrogen, C1157) was 
injected into each lobe of the thymus. Mice were sacrificed at either 6 or 24 hours. The 
thymus, spleen, and lymph nodes were collected and analyzed by flow cytometry.  
Adoptive transfer of T cells 
Mature CD24-thymocytes were isolated by Dynal negative selection using 
biotinylated anti-CD24 mAb M1/69 (Ebioscience, 13-0242-85). Cells were labeled with 
10 M CFSE and injected intravenously to CD45.1 recipients (1x106/mouse).  
Irradiation chimera 
 CD45.1+ B6 mice were lethally irradiated (11 Gy delivered in 2 installments, 4 
hours apart, as reported[191]) and reconstituted with of 2.5x106 CD45.1+ bone marrow 
cells in conjunction with equal numbers of either cKO or Ctrl bone marrow cells. 
Reconstitution was confirmed at 8 weeks from peripheral blood staining of CD45.1 and 
CD45.2. Bone marrow chimeras were analyzed for T cell numbers and phenotypes at 
10 weeks post-transplantation. 
Statistics 
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 Data was analyzed using 2-tailed unpaired Student’s t-tests.  All statistics were 
performed using GraphPad Prism, version 5 (GraphPad Software, San Diego, CA). 
*P<0.05, **P<0.01, ***P<0.001. 
 
3.4 Results 
3.4.1 Apc deficiency causes loss of naïve T cells. 
In the previous chapter, we demonstrated that an Apc deletion did not affect later stages 
of thymocyte development. Surprisingly, we observed a marked reduction of T cell 
numbers in the periphery. As seen in Fig 3.1a, the frequencies of CD4+ or CD8+ T cells 
in the cKO mice were reduced by 10-fold or more in comparison to the Ctrl mice. In 
addition to the loss of CD3+CD4+ and CD3+CD8+ T cells, approximately 1/3 of the T 
cells in the cKO mice lost expression of CD4 and CD8 (Fig. 3.1b). This loss of CD4 and 
CD8, however, is not the result of a lineage switch to ϒδ T cells, as cKO mice have 
similar numbers of  T cells in the thymus and the spleen (Fig. 3.1c and 3.1d). The 
ontogeny of these cells remains to be determined. Moreover, in both CD4+ (Fig. 3.2a) 
and CD8+ (Fig. 3.2b) T cell compartments, a profound loss of naïve T cells was 
observed in the spleen.  While more than 60% of the T cells in Ctrl mice exhibited the 
naïve phenotype, CD44loCD62Lhi, while only approximately 5% or less of the cKO T 
cells did.  In fact, most of the cKO T cells displayed markers associated with effector 
memory T cells (CD44hiCD62Llo), although significant increases in the central memory 
44 
 
compartment were also observed. In addition, expression of CD69 was also elevated in 
the cKO T cells (Fig. 3.2c).   
There are three explanations for the reduction of peripheral T cells: (1) a developmental 
blockage during thymic development, (2) a defect of thymic emigration into the 
periphery, or (3) survival defect of peripheral T cells. As seen from Chapter 2, a deletion 
of Apc did not affect thymic development, therefore, a thymic developmental blockage 
could not be an explanation for the loss of peripheral T cells.  To evaluate whether a 
defective thymic output was responsible for the loss of peripheral T cells, we injected 
CFSE intrathymically and tracked recent thymic emigrants in the periphery.  To avoid 
potential artifacts associated with peripheral labeling, we monitored the labeling of the 
thymus and excluded any samples that had less than 3% labeling of either CD4 SP or 
CD8 SP thymocytes. Moreover, since the efficacy of CFSE labeling of thymocytes is 
varies between mice, we normalized the % of CFSE+ T cells in the lymph node by 
dividing them with the % CFSE+ of either CD4 or CD8 SP thymocytes. The overall 
thymic output in cKO and ctrl were comparable, as cKO produced as many recent 
thymic emigrants as the ctrls (Fig 3.3). Thus, the reduction of peripheral T cells in cKOs 
is the not the result of aberrant thymic emigration. 
The data in Fig. 3 raised the possibility that the lack of naïve T cells is due to poor 
survival in the periphery. To test this hypothesis, we isolated CD24- mature thymocytes 
from both Ctrl and cKO mice (both are CD45.2+) and transferred these cells into 
congenic hosts that are CD45.1+, so that we can follow their persistence in the 
peripheral blood and lymphoid organs. As shown in Fig. 4a upper panel, similar 
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numbers of CFSE+ Ctrl and cKO T cells were observed in the spleens of the congenic 
hosts at 6 hours after transfer.  By 24 hours, the numbers of cKO T cells in the spleen 
were less than 1/3 of their Ctrl counterparts.  The frequencies of cKO T cells in the 
pooled lymph nodes were reduced by more than 10-fold (Fig. 3.4b). The rapid loss of 
adoptive transferred cells demonstrate a survival defect in cKO T cells. 
To further demonstrate that this disappearance of cKO was due to apoptosis, we 
evaluated cell death via 7-AAD and Annexin V staining at 6 hours post-transplant, when 
we could detect similar percentages of CD45.2+ in both Ctrl and cKO. As seen in Fig 
3.4c, there was a higher % of 7-AAD+ and/or Annexin V+ T cells in the cKO mice (Fig. 
3.4c). Taken together, data in Fig. 4 demonstrates that  while T cell emigration from the 
thymus was unaffected by the deletion of the Apc gene, increased apoptosis lead to 
reduced accumulation of Apc-deficient T cells after their emigration from the thymus.   
3.4.2 Naïve Cell death in Apc deficient T cells is cell intrinsic 
To determine whether the loss of peripheral T cells in the cKO mice was cell intrinsic, 
we created bone marrow chimeras using cKO or Ctrl donor-type (CD45.2) cells mixed 
with an equal number of recipient-type (CD45.1) bone marrow cells.  This allowed for 
both cKO and Ctrl thymocytes to develop into naïve T cells in the same environment 
(same MHC/antigen interactions and cytokines). After 10 weeks, we harvested the 
thymi and spleens to investigate the reconstitution of CD45.2+ donor cells.  As shown in 
Fig. 3.5a, the percentage of CD45.2+ cells in the thymus was unaffected by the deletion 
of Apc. Based on the distribution of CD4 and CD8 markers, the development of both 
Ctrl and cKO thymocytes was grossly normal, as all major subsets were present among 
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CD45.2+ thymocytes (Fig. 3.5b).  However, the percentage of SP thymocytes were 
reduced by approximately 2-fold (Fig. 3.5b), perhaps due to a subtle survival 
disadvantage of the cKO thymocytes, as described in Chapter 2. In the context of a 
competitive reconstitution, the apoptosis of cKO thymocytes is further amplified. To 
further elucidate whether a deletion of Apc can affect thymic egress, we assessed the 
percentages of mature SP thymocytes, using the markers: Qa-2 and CD24. Among SP 
thymocytes, the percentages of Qa-2hi and CD24lo thymocytes were comparable 
between cKO and Ctrl groups (Fig. 3.5c). Therefore a deficiency of Apc does not cause 
preferential accumulation of mature thymocytes. 
In sharp contrast to a roughly normal thymocyte development, severe cKO T-cell loss 
was observed in the spleens of chimera mice.  Thus, while the frequency of CD45.2 
donor leukocytes was unaffected by Apc deletion (Fig. 3.6a, b), more than a 20-fold 
reduction was observed in the frequency of T cells within the CD45.2 splenocytes (Fig. 
3.6c, d).  In addition to the loss of T cell cellularity, the remaining T cells exhibited a 
marked difference in cell surface markers. Even though the majority of the Ctrl T cells 
displayed CD44loCD62Lhi markers of naïve T cells, most of the cKO T cells had either 
central or effector memory markers (Fig. 3.6e, f). Loss of naïve T cell markers and 
acquisition of memory/effector T cell markers in cKO T cells were reminiscent of what 
was observed in the Ctrl and cKO mice. On the other hand, cellularity of the recipient-
type T cells was not affected in a trans-fashion by the genotype of the donor-type cells 
in the recipients (Fig. 3.7a and 3.7b).  Since the cKO T cells have developed and 
emigrated into a normal environment, both the loss of cellularity and the acquisition of 
activation markers following Apc deletion is cell-intrinsic. 
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3.4.3 cMyc over-expression contributes to apoptosis in mature T cells 
cMyc is a -catenin target gene that causes T-cell apoptosis through promotion of 
Fas/FasL interaction, and increased expression of death ligand tumor necrosis factor, 
and tumor necrosis factor related apoptosis-inducing ligand [44-46]. As the first step to 
investigate its potential contribution to T cell death in cKO mice, we evaluated cMyc 
upregulation in CD24- thymocytes from Ctrl and cKO mice by quantitative PCR. As 
shown Fig 3.8a, the cMyc transcript was doubled in the thymocytes of cKO mice. 
However, cMyc protein was not obviously upregulated among the mature thymocytes.  
In contrast, peripheral cKO T cells had drastically higher levels of cMyc than Ctrl T cells 
(Fig 3.8b).  We therefore generated the cMycfl/+Apcfl/fl;CD4-Cre+ (Myc+/-cKO) mice to 
diminish the impact of the transcriptional activation of cMyc by eptopic Wnt signaling.  
Using PCR to detect the deletion of cMyc on the DNA level, we isolated peripheral T 
cells from either ctrl cre(-) or Apc-/-cMyc+/-. As shown in Fig 3.8c, only Apc-/-cMyc+/- 
splenic T cells efficiently deleted one allele of cMyc, while cntrl splenic T cells still 
retained both wildtype alleles. Heterozygous deletion of cMyc resulted in a substantial 
reduction of the cMyc protein (Fig. 3.8b) and partially restored the numbers of cKO T 
cells in the periphery,  as an approximately 3-fold increase of both CD4 and CD8 T cells 
was also observed in Myc+/- cKO mice in comparison to cMyc+/+cKO  mice (Fig. 3.9d, e). 
By reducing the transcriptional levels of cMyc, we are thereby able to observe an 
increase of naïve T cells in the periphery by decreasing naïve cell death.  To further 
demonstrate that upregulation of cMyc caused apoptosis of Apc-/- T cells, we adoptively 
transferred either Apc-/- or Apc-/-cMyc+/- mature thymocytes into WT mice and followed 
the survival of the T cells in the host at 6 hours post-injection. As shown in Fig. 3.9a, 
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Apc-/-cMyc+/- T cells exhibited reduced apoptosis and therefore increased survival in the 
WT hosts.  This data demonstrates that the poor survival of Apc-/- T cells can be 
rescued by down-regulation of cMyc expression. In addition to an overall increase in T 
cell numbers, the % of naïve CD4 and CD8 T cells increased by 3-fold or more, while 
that of naïve CD8 T cells increased by 50% (Fig. 3.9b, c).  A corresponding reduction of 
central and effector memory T cells was also observed in CD4 T cells, although the 
accumulation of effector memory CD8 T cells was less affected by an cMyc deletion 
(Fig. 3.9 b,c). 
Our data in Fig. 3.8b demonstrated that heterozygous deletion of cMyc failed to reduce 
cMyc protein levels in cKO mice to WT levels. To determine whether the partial effect of 
a heterozygous cMyc deletion was due to an insufficient reduction in cMyc protein, we 
generated mice with a homozygously floxed cMyc locus. To validate that deleting both 
alleles of cMyc only affected peripheral T cell functions, but not thymocyte development, 
we analyzed thymocyte development by flow cytometry.  Deletion of cMyc had no effect 
on thymocyte development (Fig. 3.10a) and T cell cellularity in the periphery (Fig. 
3.10b), although a reduction of CD44 levels was observed on both CD4 and CD8 T cells 
(Fig. 3.10c). Combinational deletion of both Apc and cMyc did not affect thymocyte 
development (Fig. 3.10d). However, a homozygous deletion of cMyc resulted in a 
further rescue of T cell survival defects in the cKO mice, although it did not completely 
restore T cell cellularity and survival defects (Fig. 3.10, f).   
3.4.4 mTOR activation contributes to apoptosis in mature T cells 
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Recently, it has been shown that APC directs mTOR signaling via GSK3β’s negative 
regulation of TSC2 [103]. Because mTOR activation results in loss of quiescence in 
naïve T cells [97], we hypothesized that the loss of APC and resulting loss of naïve T 
cells may also be the result of activation of mTOR signaling. To test this hypothesis, we 
detected a well-known downstream target of mTOR signaling: phosphorylated S6 [192]. 
Using intracellular staining, we found that cKO CD4+ and CD8+ splenocytes had 
increased levels of phosphorylated S6, indicative of higher mTOR signaling (Fig 3.11a). 
To confirm this increase in peripheral T cells, we isolated T cells from the spleen and 
lymph nodes from cKO and ctrl mice via Miltenyi biotec’s pan T cell isolation kit. From 
western blot analysis, we observed significantly higher levels of phosphorylated S6 in 
cKO than in Ctrl T cells (Fig 3.11b). This data demonstrates that the loss of APC results 
in the activation of mTOR signaling as seen by the increase of phosphorylated S6 
expression. 
It is known that constitutive activation of mTOR signaling results in the activation of p53, 
thus sensitizing cells to apoptosis [193]. It is possible that activation of mTOR may be 
also contributing to the increased rate of apoptosis through p53. To detect p53 levels, 
we isolated peripheral T cells from Ctrl and cKO and blotted for p53. Though western 
blot analysis, cKO have higher levels of p53, thus the loss of APC allows increased 
mTOR signaling, which then may cause the activation of p53. (Fig 3.11c).  
To establish whether mTOR activation is involved in cKO naïve T cell death, we used a 
well-known inhibitor of mTOR, rapamycin, to rescue cell death in vitro. Ctrl or cKO 
thymocytes were treated with varying concentrations of rapamycin in vitro for an 
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overnight culture, then assayed for cell death using Annexin V and 7-ADD staining. As 
seen in figure 3.11d, inhibition of mTOR via treatment of rapamycin does decrease 
apoptosis at very low concentrations for CD4 SP thymocytes, but not for CD8 SP 
thymocytes.  
We also tested mTOR inhibition in vivo (4 mg/kg, every other day), however, rather than 
rescuing naïve T cell death, at least 60% of the cKO rapamycin-treated mice had died, 
while ctrl vehicle/rapamycin treated or cKO vehicle treated all survived (Fig 3.12a). 
Rapamycin-treated cKO mice exhibited massive weight loss by day 3 of treatment if 
rapamycin was given daily (Fig 3.12b). Since rapamycin treatment cause rapid and 
severe health deterioration, we hypothesized that this was consist with a cytokine storm. 
Using serum for ctrl or cKO mice treated with rapamycin or vehicle over a 3 day period, 
we measured pro-inflammatory cytokines levels using a cytokine bead array assay. cKO 
rapamycin treated mice producde more pro-inflammatory cytokines, particularly TNFα 
(Fig 3.12c). Intracellular staining confirmed that the cells that produced the pro-
inflammatory cytokine, TNFα, were T cells (Fig 3.12d). 
3.5 Discussion  
Though many studies have shown the importance of extrinsic factors, such as MHC 
interactions and cytokines, very little is known about the intrinsic cell programs that are 
involved in naïve T cell survival. Due to the heavy emphasis on Wnt signaling in either 
thymocyte development or T effector cell differentiation, little has been studied on the 
role of Wnt in naïve T cells. In this study, we report a possible role of Wnt signaling in 
naïve T cells. Thus, Wnt signaling joins other transcription factors (FOXO1, FOXO3, 
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FOXP1, KLF2) known to promote naïve T cell survival. However, while these 
transcription factors were shown to control the expression of IL-7R [99-101], we have 
not observed any effect of Wnt signaling on IL-7R levels.  
We demonstrated that this loss of Apc and resulting in ectopic activation of Wnt leads to  
the upregulation of cMyc, which is known to play a role in activation cell death via 
through Fas/FasL interaction, death ligand tumor necrosis factor, and tumor necrosis 
factor related apoptosis-inducing ligand [44-46]. Though the deletion of cMyc in cKO 
mice does attenuate cell death and CD44 expression, naïve T cell numbers are not 
entirely rescued, suggesting that there are other pathways involved in loss of naïve T 
cells. To test whether the apoptosis in cKO T cells were associated with cMyc’s 
regulation of death ligand expression (extrinsic apoptosis pathway) or the intrinsic 
apoptosis pathway, we detected the levels of either caspase 8 (implicating the extrinsic 
apoptosis pathway) or caspase 9 (implicating the intrinsic apoptosis pathway). We 
observed an upregualtion of both caspases (data not shown), suggesting that both 
pathways are involved in the observed cell death in cKO T cells. Due to the involvement 
of both p53 and caspase 9, it is worth exploring the role of Apc in regulating the intrinsic 
apoptosis pathway in naïve T cells.  
Previous reports have demonstrated that Wnt activates mTOR through inactivation of 
GSK3, which is critical for Tsc function. Here we showed that Apc deletion resulted in 
increased mTOR activation.  Since our group and others have also shown that mTOR 
signaling regulates naive T cell quiescence [78, 174], we attempted to decrease mTOR 
activation via rapamycin treatment. We show that rapamycin rescues CD4 SP 
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thymocyte cell death via inhibition of mTOR signaling, however this is not observed in 
CD8 SP thymocytes. This may be due to the fact that CD8 T cells are more sensitive to 
mTOR activation as seen in TSC1 cKO T cells as seen in the deletion of TSC1 and the 
resulting mTOR activating significantly affected CD8 T cells more than CD4 T cells [78, 
174].  
We also have attempted to rescue T cells by rapamycin. Surprisingly, rapamycin 
caused severe weight loss, increased production of pro-inflammatory cytokines 
specifically in the cKO mice.  Although rapamycin is known for its uses as an 
immunsuppressive, but it also has been shown to have pro-inflammatory effects: 
kidney-transplant recipients developing post-transplantation glomerulonephritis and 
proteinuria after rapamycin treatment [194, 195] and transplant patients developing 
anemia and increased pro-inflammatory cytokines post-rapamycin treatment[196]. It has 
been previously reported that treatment of monocytes with rapamycin, in conjunction 
with LPS or bacteria, promotes pro-inflammatory cytokine production dependent on the 
transcription factor NF-κB [197]. Here we found that loss of Apc resulted in a moderate 
increase of TNFα production in T cells, which is massively elevated by treatment by 
rapamycin. This observation is paradoxical as mTOR activation was generally 
associated with increased production of inflammatory cytokines. How a deletion of Apc 
alters the function of mTOR is of great interest and deserves further investigation. 
Weichhart et al. demonstrated that it is the TSC2-mTOR pathway that mediates the 
effects of rapamycin to produce pro-inflammatory cytokine. In light of this observation, 
we suggest that inactivation of Apc resulted in inactivation of Tsc2, which need to be 
balanced by high mTORC1 activity to prevent cytokine storm. 
53 
 
It would be also interesting to dissect the role of Wnt and mTOR in the control of the cell 
cycle in cKO T cells, for both pathways have been implicated in regulation of the cell 
cycle. APC’s other regulatory roles, independent of Wnt signaling, are also worth 
examining. For instances, APC’s role in chromosomal stability may also be a 
contributing factor in the loss of peripheral T cells, which may explain the upregulation 
of p53 due to DNA damage. cMyc is also known to be important in p53-dependent 
apoptosis, where cMyc deficient cells are do not undergo apoptosis due to DNA 
damage due to the inability to upregulate p53 [198]. Further investigates are need to 
know whether our cMyc-/- cko T cells can undergo p53-dependent apoptosis. Our study 
has shown that Apc is a crucial regulator in naïve T cell survival by controlling levels of 
cMyc and mTOR activation. 
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Figure 3.1 
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Fig. 3.1. T-lineage-specific activation of Wnt signaling causes T cell lymphopenia a. Wnt signaling causes massive 
reductions in both CD4 and CD8 T cells. Representative profile depicting the frequencies of CD4 and CD8 T cells in 6-8 
week old WT and cKO spleens are shown on the left, while the summary is presented on the right (n=13).  b. Wnt 
signaling causes loss of CD4 and CD8 markers in T cells.  Representative profiles for CD4 and CD8 markers among 
CD3+ spleen cells are shown on the left, while the summary is shown on the right (n=11).  c, d. Apc deletion by CD4-Cre 
does not cause alteration in  T cells lineages. Ctrl (open circles) and cKO (filled squares) thymocytes (a) and 
splenocytes (b) were stained with anti-TCR and anti-TCRδ complex mAbs.  The data is shown as the mean and SEM of 
%  T cells, summarized from two independent experiments involving 6 mice at 6-8 weeks of ages in each group. 
 
56 
 
 
Figure 3.2 
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Fig. 3.2. Wnt signaling causes loss of naïve CD4 (a) and CD8 (b) T cells in the spleen.   Left panels show representative 
profiles depicting the distribution of CD44 and CD62L markers, while the right panels show the summary of the 
frequencies of naïve (CD62Lhi CD44lo), central memory (CD62Lhi CD44hi), or effector memory (CD44hiCD62Llo) cells 
(n=13). c. Increased CD69 expression among cKO T cells.  Data presented are % of CD69+ T cells among CD4 and CD8 
T cells (n=9). Data are either representative or summary of those from at least three independent experiments. 
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Figure 3.3 
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Figure 3.3.  
Thymic output is not affected by an Apc deficiency in the T cell linenage. Thymocytes were labeled by intrathymic 
injections of CSFE.  After 6 or 24 hours, Ctrl and cKO thymi and lymph nodes were harvested to analyze the frequency of 
CFSE+ CD4 or CD8 T cells. FACS profiles depicting the CFSE+ cells among gated CD4 or CD8 T cells in the thymus or 
lymph nodes are presented in a, while the summary from one experiment involving 6-14 mice per group from 2-3 
independent experiments are shown in d.   Rare mice with <3% labeling of either CD4 or CD8 SP thymocytes were 
excluded from the analyses 
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Fig. 3.4. Rapid loss of mature cKO thymocytes in the periphery.  CD24- mature T cells were isolated from Ctrl or cKO 
mice (CD45.2) and injected intravenously into congenic CD45.1 mice.  The frequency of CD45.2+CFSE+ cells in the 
spleen (a) or lymph nodes (b) are summarized from three independent experiments.  c. Increased apoptosis of mature 
cKO thymocytes at 6 hours after adoptive transfer.  % apoptosis was detected via staining of 7-AAD and Annexin V.  
Representative FACS profiles are shown in the left, while summary data involving 3-4 mice per group were shown in the 
right.  The data have been reproduced in two independent experiments. 
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Figure 3.5 
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Fig. 3.5.  Grossly normal development of Apc-deficient T cells in bone marrow chimera mice.  Bone marrow chimeras 
were generated by injecting 2.5x106 of either Ctrl or cKO bone marrow cells, in conjunction with an equal number of 
recipient CD45.1-type bone marrow cells into lethally irradiated mice.  Mice were sacrificed 10 weeks after bone marrow 
transplantation. For all panels, representative profiles are shown on the left, while the summarized data from one 
experiment involving 4 mice per group are presented on the right.  All data have been reproduced in two independent 
experiments. a. In the chimeric mouse thymus, Apc deletion does not affect thymocyte production.  Data shown are 
frequencies of donor-derived T cells.  b. Development of CD45.2+ thymocytes was assessed based on the distribution of 
CD4 and CD8 markers. c. Normal thymocyte maturation was assessed based on CD24 and Qa-2 expression on donor-
type CD4 SP and CD8 SP thymocytes.  
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Figure 3.6 
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Fig. 3.6. T-cell intrinsic function of Wnt signaling and T cell survival. a, b. Chimerism in 
the spleen was assessed based on the expression of congenic markers.  c, d. Cell-
intrinsic lymphopenia after lineage-specific Apc deletion was assessed based on 5-color 
flow cytometry using antibodies specific for CD45.1, CD45.2, CD3, CD4, and CD8. e, f. 
Spontaneous loss of naïve T cells is due to cell-intrinsic Apc deletion. The frequencies 
of naïve, central, and effector memory T cells were determined using CD45.2, CD44, 
CD62L, CD4 and CD8.  Representative FACS profiles are shown in a, c and e, while 
summary data from two independent experiments involving 4 mice per group are shown 
in b, d and f. 
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Figure 3.7 
 
 
 
 
 
 
Figure 3.7 (a and b) In mixed bone marrow chimeras, Apc deletion by CD4-Cre in 
donor-type T cells does not affect the development and survival of recipient-type T cells.  
a. % WT CD45.1+ recipient-type cells developed in the presence of either Ctrl (open 
bars) or cKO (filled bars) donor-type (CD45.2+) cells. b. As in c, except spleen cells 
were analyzed.  The data is shown as the mean and SEM, summarized from 3 
independent experiments, n=10. 
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Figure 3.8 
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Fig. 3.8. Heterozygous deletion of cMyc partially attenuate loss of T cells caused by 
Apc deletion.  a. Apc deletion increases cMyc mRNA in CD24- mature thymocytes as 
measured by quantitative PCR. Data shown are means+/- SEM (n=3). These data have 
been reproduced 3 times. b. Western blot analysis of c-Myc protein in pooled CD24- 
mature thymocytes from Ctrl (n=3), cMyc+/-cKO (n=6), and cMyc+/+cKO (n=9).  These 
data have been reproduced twice. c. Representative profiles of CD4 and CD8 T cells in 
Ctrl, Myc+/-cKO, or cKO spleens. d. Summary of the frequencies of CD4 or CD8 T cells 
in in Ctrl, Myc+/- cKO, or cKO spleens (n=9).   e. detect of deletion of cMyc allele by PCR 
of splenic T cells from either control or Myc+/- cKO mice.  
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Figure 3.9 
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Figure 3.9. Heterozygous deletion attenuates apoptosis and partially restore naïve T 
cells. a. Heterozygous deletion of cMyc in T cells attenuates apoptosis of CD24- mature 
thymocytes at 6 hours after adoptive transfer via intravenous route. Aliquots of 1x106 
CFSE-label thymocytes were injected into congenic CD45.1 recipients. Apoptosis was 
measured by staining with 7-AAD and Annexin V. Data shown are means and SEM 
(n=9). b. Representative profiles depicting the distribution of CD44 and CD62L markers 
on CD4 and CD8 T cells in Ctrl, Myc+/- cKO, or cKO spleens. c. Frequencies of naïve, 
central memory, or effector memory splenic T cells in 6-8 week old Ctrl, cMyc+/-cKO, or 
cKO mice (n=9). Data from a-c are either representative or summary of those from three 
independent experiments. 
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Figure 3.10 
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Fig. 3.10. Homozygous deletion of cMyc substantially rescues lymphopenia and 
spontaneous activation of Apc-deficient T cells. a-c. cMyc deletion has minimal impact 
on thymocyte development  and  T lymphocyte cellularity  but reduces CD44 expression 
in spleen T cells. a. Representative profiles depicting thymocyte development based on 
distribution of CD4 and CD8 markers. b. Deletion of cMyc does not significantly reduce 
T cell cellularity.  Summary data showing the frequencies of CD4 and CD8 T cells, data 
shown are means and SEM (n=9). c. cMyc deletion reduces CD44 expression.  Data 
shown are means and SEM (n=9) of mean fluorescence intensities, depicting CD44 
expression among CD4 and CD8 T cells. d. Summary data on thymocytes subsets 
among 6-8 weeks old mice with or without deletion of Apc and genes.  Data shown are 
means and SEM (n=9). e. Frequencies of CD4 or CD8 T cell from Ctrl (n=6), cKO (n=2), 
or, cMyc+/-cKO (n=5), or cMyc-/-cKO (n=3).  f. Frequencies of naïve, central memory and 
effector memory T cells in the spleen from Ctrl (n=6), cKO (n=2), Myc+/- cKO (n=5), or 
cMyc-/-cKO (n=3) mice.  
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Fig. 3.11. Deletion of Apc results in hyperactivation of mTOR signaling a. Splenocytes 
were isolated from 6-8 week cntrl and cKO mice. Cells were for surface markers (CD3, 
CD4, and CD8). Cells were permeablized, then stained with anti- pS6 (1:30) or an 
isotype control. Similar data were obtained in 3 independent experiments, involving 9 
mice per group in total. (b and c). Splenocytes were isolated from cntrl or cKO mice. T 
cells were isolated using Macs pan T cell kit through negative selection. T cells were 
lysed in RIPA buffer. Protein levels were analyzed using western blot analysis. These 
data have been repeated twice. d. thymocytes from ctrl or cKO mice were cultured 
overnight in RMPI with 10%FBS, pen/strip, and 50mM of 2-Me with varying 
concentrations of rapamaycin (0-5 nm). Apoptosis was detected via Annexin V and 7-
AAD staining. This experiment was repeated twice with 3 mice per group in each 
experiment.
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Fig. 3.12. Treatment of rapamycin in vivo results in massive cytokine storm in mice with 
T cell specific Apc deficiency. a. ctrl or cKO mice were treated every other day for 2 
weeks with 4 mg/kg of rapamycin or vehicle control (n=6) . Survival was recorded for 2 
weeks. b. ctrl (n=3) or cKO mice (n=4) were treated with 4 mg/kg of rapamycin daily 3 
times. Weight was recorded daily. c. Serum was collected on day 3 post-treatment and 
cytokine levels were determined using a pro-inflammatory bead array assay. d. 
Splenocytes were treated in vitro for three days with rapamycin. On day three, cells 
were treated with PMA (500 ng/mL) and ionomycin (500 ng/mL) to stimulate T cell 
cytokine production for 4 hours. Golgi blockers was added by hour 2.  Cells were gated 
on CD3+ splenic T cells and TNFα production was analyzed. (n=4). 
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Chapter 4 
T-cell Intrinsic Deletion of the Adenomatous Polyposis Coli Gene Causes 
Homeostatic Proliferation and Inflammatory Bowel Disease 
4.1 Abstract 
Many autoimmune diseases have been linked to lymphopenia, a conditional associated 
with lower than normal lymophocytes. However, to our knowledge, none of the known 
single gene defects that cause lymphopenia are sufficient to cause autoimmune 
diseases. In addition, the intracellular programing involved in lymphopenia-driven 
homeostatic proliferation (HP) remains to be elucidated. Using a conditional knockout of 
adenomatous polyposis coli (Apc) under the control of CD4-cre, we showed that Apc 
deletion causes both T cell activation, lymphopenia and HP. Using this mouse model, 
we studied the association between lymphopenia-driven HP, and autoimmune diseases. 
We showed that APC deficiency and the resulting activation of Wnt signaling in T cells 
causes a fatal inflammatory bowel disease with Crohn’s disease-like pathology.   
Development of autoimmune diseases requires lymphopenia. This data provide the first 
genetic evidence that a T-cell intrinsic single-gene defect is sufficient to cause 
lymphopenia, HP and autoimmune diseases. 
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4.2 Introduction 
Many human autoimmune diseases, including type 1 diabetes [156-158, 199], 
rheumatoid arthritis [150-154, 200, 201], Sjogren’s syndrome [161], systemic lupus 
erythematous [143, 145, 146], inflammatory bowel diseases (IBD) [140, 202, 203], and 
celiac disease [204, 205], have been associated with lymphopenia [206]. Transient 
lymphopenia caused by rubella infections is linked to autoimmune diabetes mellitus 
[207, 208], while Parvovirus B19 infection is to associated with rheumatoid arthritis [209, 
210] and multiple sclerosis risk is linked to common childhood infections [211]. The link 
between autoimmune disease and lymphopenia has been demonstrated in various 
mouse models of autoimmune diseases including: IBD, gastritis, and diabetes. The 
mouse model of inflammatory bowel disease (IBD) involves HP by transferring T cells 
into a lymphopenic host. In addition, mice that were thymectomized at day 3 of age, and 
therefore lymphopenic, developed gastritis, caused by expansion of T cells that were 
specific to a self-antigen, H/K ATPase [212, 213].  Furthermore, nonobese diabetic 
(NOD) mice develop diabetes due to the destruction of β-cells by T lymphocytes. This T 
cell-mediated autoimmune disease was linked to the reduction of T cell numbers, as 
diabetes was alleviated by infusing NOD mice with syngeneic T cells.  
Lymphopenia participates in the pathogenesis of autoimmune disease via a process 
known as T cell HP. HP occurs when T cell numbers decrease, and they 
homeostatically expand [130-132, 214]. HP is distinct from T cell expansion in response 
to a foreign antigen, as it allows for expansion of T cells that have a low affinity for self-
antigens. These self-reactive T cells become activated and acquire features of memory 
T cells, including expression CD44 and Ly6c markers and producing IFNϒ, granzyme 
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B, and perforin following short-term PMA stimulation [129-133]. Therefore, HP allows for 
the proliferation and activation of possible self-reactive T cells creating an environment 
for the development of autoimmunity. 
In addition to lymphopenia, It has also been suggested that gut associated microbes 
also are required for optimal HP. When CD4+ T cells were transferred into SCID mice 
maintained under germ-free conditions, these T cells had reduced HP [215]. Other 
regulators of HP include a surface co-inhibitory molecules. BTLA deletion in T cells 
exacerbate HP [216], while deletion of CD24, in T cells, attenuates it [217].  While T 
regulatory cells do not suppress HP, co-transfer of T regulatory cells prevented 
inflammatory bowel diseases caused by CD45RBhi CD4 T cells [140, 142, 203, 218].  
Though lymphopenia seems to be interconnected with autoimmunity, it alone is not 
sufficient to cause autoimmunity. The model of IBD and also of gastritis requires, not 
only lymphopenia, but the lack of T regulatory cells to cause disease. In addition, T cell-
mediated diabetes in NOD mice requires a specific background of mouse that over-
produces IL-21, a cytokine that aids in HP [137]. Therefore, while lymphopenia appears 
to play a role in the etiology of autoimmunity, the link between lymphopenia and 
autoimmune disease remains to be strengthened in at least two levels.  First, although a 
number of genetic studies have indicated that lymphopenia can be caused by deletion 
of genes involved in T cell development [219-221], emigration [91, 222], and 
maintenance of quiescence [97, 223], to our knowledge, none of these mutations alone 
are sufficient to cause autoimmune disease.  Second, although it is well established that 
T cells undergo homeostatic proliferation in response to lymphopenia and acquire 
memory phenotypes [131, 214], the lack of understanding of  the intracellular program 
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for lymphopenia-driven HP makes it difficult to definitively assess how lymphopenia and 
its associated HP serve as drivers for autoimmune disease.  In this context, although 
the cytokines IL-7, IL-15 [186, 224], and IL-21[158], the cell surface protein CD24 [217, 
225], and the interaction of TCR with self-peptide-MHC [127, 130, 138, 226] all 
contribute to HP in response to lymphopenia for naïve T cells, the intracellular signaling 
pathway responsible for lymphopenia-driven HP is largely uncharacterized.  From the 
previous chapters, we have shown that a deletion of Apc does not affect thymocyte 
development, but instead, causes T cell death in naïve T cells. The resulting 
lymphopenia allows us to further elucidate a link between HP and autoimmune disease. 
Here, we show that lymphopenia and activation of Wnt signaling by Apc deletion in T 
cells causes HP and inflammatory bowel disease (IBD). These data greatly strengthen 
the link between lymphopenia, HP, and autoimmune disease. 
 
 4.3 Materials and Methods 
Mice 
CD45.1 C57BL/6 mice were obtained from Charles River Laboratories through a 
contract with the National Cancer Institute.  Mice with homozygous knockin of the 
Floxed Apc [173] or Ctnnb1 [227] loci and transgenic mice expressing the Cre 
recombinase under the control of CD4 promoter [175] were obtained from Jackson 
Laboratories (Maine, USA).  Mice with floxed cMyc locus [190] were kindly provided by 
Dr. De Alboran.  All mice used in this study have been backcrossed to C57BL/6 
background for at least 10 generations.  These strains were maintained in our animal 
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facilities under pathogen-free conditions.  All experiments were in accordance with 
guidelines of the Institutional Animal Care and Use Committee of University of Michigan 
and the Children’s National Medical Center. 
Flow cytometric analysis 
Single cell suspensions were stained at 4ᵒC for 20 minutes in phosphate-buffered saline 
with 2% FBS with the following antibodies (BD Bioscience, 1:200): CD4 (RM4-5, 25-
0042-82), CD8 (SK-1, 8066-0087-120), B220 (HIS24, 25-0460-82), Samples were 
analyzed by using BD LSR II Flow Cytometer. Ki-67 (SolA15, 12-5698-82) staining was 
performed by fixing and permealbilizing cells at room temperature for 30 minutes using 
perm/fix buffer (BD Bioscience, 554714) and stained at 1:200 at 4ᵒC overnight. For 
staining of intracellular cytokines, mononuclear cells were stimulated for 6 hours with 
PMA and ionomycin in the presence of golgi blocker (BD Bioscience, 554724) prior to 
staining using the same methods.  
CFSE dilution experiments 
T cells isolated from the Ctnnb1f/f;CD4-Cre- (WT) or Ctnnb1f/f; CD4-Cre+ (Ctnnb1-/-) mice 
were labeled with 10 µM CFSE (Invitrogen, C34554) and injected intravenously (106 
cells/mouse) into 550 Rad-irradiated congenic mice as described [217, 225] .  Five days 
later, spleen cells were harvested and analyzed for CFSE dilution among the 
CD45.2+CD3+ T cells.   
Irradiation chimera 
Two types of bone marrow chimeras were created.  First, CD45.1 mice that had 
received 6 Gy irradiation were reconstituted with 1x106 bone marrow cells from 
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Apcf/f;CD4-Cre- (Ctrl) or Apcf/f;CD4-Cre+ (cKO) mice were analyzed for the presence of 
B220+ B cells and T cells at 6 weeks after transplantation.  The mice were observed for 
survival using weight loss of greater than 20% as the endpoint.  Second, CD45.1+ B6 
mice were lethally irradiated (11 Gy delivered in 2 installment 4 hours apart, as reported 
[228]) and reconstituted with 2.5x106 CD45.1+ bone marrow cells and an equal number 
of either cKO or Ctrl bone marrow were observed for the development of survival and 
the % of Ki67+ T cells in the PBL.  
Statistics 
Data was analyzed using 2-tailed unpaired Student’s t-test.  All statistics were 
performed using GraphPad Prizm, version 5 (GraphPad Software, San Diego, CA). 
*P<0.05, **P<0.01, ***P<0.001. 
4.4 Results and Discussion 
4.4.1 APC deficiency causes loss of naïve T cells that results in homeostatic 
proliferation and autoimmune disease.  
In chapter 3, we demonstrated that a deletion of Apc resulted in naïve T cell death, 
resulting in lymphopenia and highly activated T cells. To determine whether Apc 
deficient T cells undergo HP in response to lymphopenia, we used Ki-67 expression as 
a marker to study cycling T cell in vivo.  As shown in the left panel of Fig. 4.1a and 
summarized in Fig.4.1b, cKO T cells had 5-fold more Ki-67+ T cells than Ctrl T cells.  To 
determine whether cKO T cell proliferation is the result of lymphopenia we created 
chimeras consisting of bone marrow from either ctrl or cKO (CD45.2+) in conjunction 
with CD45.1+ WT bone marrow. We demonstrated in Chapter 3 and in Fig 4.2 that cKO 
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bone marrow is unable to fully reconstitute the peripheral T cell compartment, but the 
host will not be lymphopenic as the CD45.1+ bone marrow is able to fill this loss.  Thus, 
by creating bone marrow chimeras, we can determine whether the observed 
proliferation of cKO can be prevented by restoring T cell cellularity. Again using Ki-67 as 
a marker of proliferation, we compared the Ki-67 expression in cKO T cells in a 
lymphopenic host with those in a non-lymphopenic host. As shown in the right panel of 
Fig. 4.1a and summarized in Fig 4.1b, the percentage of proliferating cKO T cells was 
reduced in chimera mice due to filled T cell compartment comprised of CD45.1+ T cells.  
Therefore, the proliferation of cKO T cells is considered homeostatic in nature. 
Remarkably, the majority of the mice with T-lineage-specific deletion of Apc developed 
rectal prolapse, with blood in the feces, diarrhea, and weight loss (data not shown).  
Most of the cKO mice died within 100 days of age, while most Ctrl mice survived 
throughout the observation period of 300 days (Fig. 4.3a).  Gross anatomical images 
revealed severe swelling in the colon (Fig. 4.3b).   
We conducted a histological analysis of all internal organs and found pathological 
changes limited to both the small and large intestines, a pathology more similar to 
Crohn’s disease than ulcerative colitis. As shown in Fig. 4.3c, leukocyte infiltration was 
observed in both the small intestines (top panels) and the colon (middle panels), with a 
severe loss of mucin production by the colon epithelial cells (bottom panels) and a 
significant thickening of the colonic muscular layer (middle panels). Together, the bias 
toward Th1 and Th17, the involvement of both small intestines and colon and, 
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histopathological features further support the notion that the disease resembles Crohn’s 
disease. 
To determine whether this pathogenesis is linked to cKO T cells, we investigated known 
cytokines that have been shown to play a role in driving the pathogenesis of 
inflammation in the intestines: IL-17A and IFN-We observed significant elevation of 
IFN-producing Th1 CD4 T cells and IL-17-producing Th17 cells in the spleen and 
mesenteric lymph nodes (Fig. 4.4a-d).  The bias towards Th1 and Th17, the 
involvement of both the small intestines and colon, and the histopathological features, 
such as increased thickness of muscular layer and inflammation in smooth muscle 
layer, were highly suggestive of Crohn’s disease [229]. 
Genome wide analysis studies (GWAS) have correlated many genes involved in Th17 
differentiation: IL-12B, JAK2, IL23R, STAT3, CCR6, and TNFSF15, to susceptibility to 
Crohn’s disease [202, 230, 231]. It is possible that the loss of Apc may result in a 
predisposition of cKO T cells to differentiate into disease-causing Th17 cells. To 
establish whether Apc can regulate Th17 polarization, we polarized mature CD24- CD4 
SP thymocytes. Though the standardized protocol for T helper cell polarization requires 
the use of naïve CD4 T cells, unfortunately, peripheral cKO T cells are predominantly 
effector T cells; thus, we use mature CD24- CD4 SP thymocytes. After polarization, cKO 
thymocytes do have a tendency to differentiate IL-17A-producing Rorγt expressing Th17 
cells (Fig 4.4e). cKO T cells have a higher predisposition to differentiate into Th17 cells.  
To show that the autoimmune disease can be prevented by the addition of T cells to 
create a lymphoreplete environment is the gold standard of determine whether an 
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autoimmune disease is due to homeostatic proliferation.  To address this issue, we 
generated bone marrow chimera consisting of both WT CD45.1+ T cells and cKO T cells 
in order to fill the T cell compartment, thus preventing HP (Fig. 4.2).  To determine 
whether the infusion of WT T cells in chimera mouse corrected the survival defects, we 
compared the survival of chimera mice with cKO mice.  As shown in Fig. 4.3a, all of the 
chimera mice survived throughout an observation period of 300 days.  Therefore, 
provision of WT T cells in the same host prevented both lymphoproliferation and IBD.   
4.4.2 A critical role for Wnt signaling in T cell homeostatic proliferation   
The link between Apc deletion and homeostatic proliferation (Fig. 4.1) suggested a 
critical role for Wnt signaling in homeostatic proliferation.  To verify this, we crossed the 
floxed Ctnnb1 locus into the cKO mice to generate Apcfl/flCtnnb1fl/fl;CD4-Cre+ mice.  
Unfortunately, the T cells developed in the Apcfl/flCtnnb1fl/fl;CD4-Cre + mice retained Apc  
and/or Ctnnb1 (data not shown), perhaps due to selective pressure against doubly 
deleted T cells.   
To confirm the importance of Wnt signaling, one would have to use naïve CFSE labeled 
T cells from cKO, Ctnnb1-/-, and Ctrl mice, observe their proliferation in a lymphopenic 
host.  However, cKO mice do not have an abundance of naïve T cells. If we were to 
utilize total T cells, we would be comparing cKO effector T cells to naïve Ctrl T cells; two 
distinctly different populations with different proliferation potentials. On the other hand, a 
sufficient number of Ctnnb1-/- T cells could be isolated from Ctnnb1fl/fl;CD4-Cre + mice 
(Fig. 4.5a).  To determine whether -catenin is required for homeostatic proliferation, we 
transferred CFSE-labeled Ctnnb1+/+ and Ctnnb1-/- T cells into CD45.1 congenic mice 
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that were made lymphopenic by sublethal irradiation.  Five days after adoptive transfer, 
the spleen cells were harvested to analyze the distribution of the CFSE intensities 
among the adoptively transferred CD45.2 T cells.  As shown in Fig. 4.5b and c, while 
WT T cells underwent homeostatic proliferation, the -catenin-deficient T cells barely 
divided.  Therefore, -catenin is required for homeostatic proliferation.   
4.4.3 Myc is not required for homeostatic proliferation 
Given the critical role for cMyc in the lymphopenia-induced by the Apc deletion, we 
tested if the increased Myc transcription is critical for homeostatic proliferation, using the 
Ki-67 expression in the lymphopenic host as an indication of expansion.  cMyc-/- T cells 
do have a significantly reduced proliferation rate as seen in the reduced Ki-67 
percentages in CD3+ T cells, as well as both CD4+ and CD8+ compartments (Fig 4.6). 
However, Heterozygous deletion of cMyc in cKO T cells did not appreciably reduce HP 
(Fig 4.6).  Homozygous cMyc deletion attenuated the HP somewhat, although 
substantial HP remains. The modest impact by homozygous cMyc deletion was 
observed in CD8 but not CD4 T cells (Fig. 4.6). Therefore, the genetic requirement for 
lymphopenia and homeostatic proliferation can be distinguished by cMyc.  Consistent 
with the role for homeostatic proliferation in the pathogenesis of inflammatory bowel 
disease, neither heterozygous nor homozygous cMyc deletion significantly abrogated 
the inflammatory bowel disease in the cKO mice (Fig. 4.7). 
 
 
86 
 
4.5 Discussion 
Previous studies showed that single gene mutations that resulted in lymphopenia 
appeared to be insufficient to cause autoimmune disease.  Thus, although deletion or 
shRNA silencing of the Iddm1 locus (GIMAP5) causes defective thymocyte 
development and/or loss of naïve T cells in the periphery, mice with a targeted mutation 
of the gene do not show signs of autoimmune disease within their relatively short life-
span [232-234].  Likewise, in human subjects with a hypomorphic mutation of the RAG1 
gene, which reduces lymphocyte output, none of the patients with lymphopenia develop 
autoimmune disease [235].  Furthermore, targeted mutations of the Klf2 and Tsc1 
genes, which respectively cause defective thymic emigration [91] and survival of naïve 
cells [97, 223], result in lymphopenia without autoimmune disease.  In addition, the 
development of diabetes, in NOD mice, requires lymphopenia, but also requires a 
specific background of mouse that over-produces IL-21, a cytokine that aids in HP 
[137]. 
Here, we report that T-lineage-specific deletion of Apc alone was sufficient to cause 
spontaneous and lethal autoimmune disease within 100 days of age in a C57BL/6 
background.  Deleting Apc and thereby activating Wnt signaling, causes the cKO T cells 
to be highly activated and die by apoptosis. The deficiency of Apc causes T helper cells 
to polarize to more pro-inflammatory Th17 and Th1 cell types. Previously, it has been 
shown that Tcf can bind to and activate the RorγT gene, which encodes the 
transcription factor for Th17 differentiation; through the loss of Apc, Wnt activation can 
drive Th17 development [236]. HP has also been implicated in the biased differentiation 
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of gut trophic Th17 cells [237]. It still remains to be determined if it is the activation of 
Wnt that directly drives Th17 differentiation or lymphopenia-driven HP that skewed T 
helper cell towards Th17.     
Surprising, the autoimmune disease that manifests in Apc-deficient T cells is most 
similar to Crohn’s disease, as seen by the histological analysis of the small and large 
intestines, loss of mucin-producing cells in the intestines, and pro-inflammatory cytokine 
production of IL-17A and IFNγ. Analysis of the other organs of the cKO mice revealed 
leukocyte infiltration and inflammation was limited to the small and large intestines. It is 
still unclear why the inflammation can only be observed in the intestines, but not any 
other organ, when the conditional knockout is in T cells, not an intestine specific cre-
recombinase. It is possible that the loss Apc may induce the expression of integrins 
involved in migration to the intestines, therefore preferentially causing the migration of 
highly activated cKO T cells to the intestines, causing intestinal inflammation. Also, the 
majority of the T cell compartment of cKO mice are recent thymic emigrants, due to the 
high apoptotic rates of naïve T cells. Recent thymic emigrants are known to 
preferentially migrate to the intestines [238]; perhaps this innate property of recent 
thymic emigrant migration may therefore target the intestines for the development of 
autoimmune disease. 
Not only does the loss of Apc result in a more pro-inflammatory T cell subsets, but also 
T cells that homeostatically proliferate more efficiently, thus increasing the risk of 
developing autoimmune disease. To verify HP as a driver of autoimmune disease in 
cKO mice, we created bone marrow chimeras to introduce cKO T cells in a 
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lymphoreplete environment. Though cKO T cells continue to be highly activated in the 
chimera mice, no autoimmune disease has been observed. We also demonstrated that 
Wnt signaling is required for efficient HP, by using β-catenin-deficient T cells. 
Interestingly, though cMyc was shown to play a large role in causing naïve T cell death 
in cKO mice and is also a known driver of proliferation, here we showed that cMyc does 
not control homeostatic proliferation. The underlying mechanism by which Wnt drives 
homeostatic proliferation still remains unclear. Through this study, we have shown a 
more compelling link between lymphopenia-driven HP and autoimmune disease by 
generating a single T-cell intrinsic gene defect that sufficiently drives autoimmune 
disease.   
Previous studies have suggested a genetic and epigenetic association between Crohn’s 
disease and components of Wnt signaling, including LRP6 [164] and TCF4 [163, 239].  
Most studies on Wnt signaling in IBD have focused on Wnt function in tissue remodeling 
partly because TCF4 is expressed at high levels in the intestinal epithelial cells.  Since 
the IBD described herein is initiated by Apc deletion in T cell lineages, our data suggest 
a direct role for Wnt signaling in T cells as an alternative interpretation of these genetic 
data. 
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Figure 4.1  
 
 
Fig 4.1 Enhanced HP APC cKO mice.  a. Representative profiles of Ki-67 expression in CD3+ T cells in peripheral blood of 
ctrl or cKO (left) or bone marrow chimera consisting of both WT and cKO T cells (right panel) .  b. Summarized % of Ki-67 
positive cells. n=4. These data have been reproduced in 3 independent experiments.  
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Fig. 4.2. Normal cellularity of recipient-type T cells in the chimera mice.  Bone marrow from the CD45.2+ cKO and Ctrl 
donors were mixed at a 1:1 ratio with CD45.1+ recipient-type bone marrow cells (total bone marrow cell number: 
5x106/mouse).  The mixtures were injected into lethally irradiated CD45.1+ hosts.  Mice were sacrificed at 12 weeks post-
transplantation to analyze reconstitution in the spleen. Representative profile of gated CD45.1+ cells are shown in the left 
and  on the right are absolute numbers of CD45.1+ recipient-type splenic T cells in chimera mice consists of either Ctrl or 
cKO donot-type bone marrow cells.  n=5.  
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 Figure 4.3 
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Figure 4.3.  T-lineage-specific deletion of Apc causes IBD with Crohn’s disease-like pathology: association with 
lymphopenia.a. Kaplan Meier survival curve of ctrl (green), lymphopenic cKO (red), ctrl bone marrow chimera (green 
dotted) or non-lymphopenic  cKO bone marrow chimeras (red dotted) mice. Mice were determined moribund by drastic 
weight loss, rectal bleed, or bloody diarrhea. b. Gross anatomy images showing the swelling of the colon in cKO mice.  c. 
representative H&E stains of intestines of ctrl or cKO intestines. Comparison of the histological features from the 
intestines of Ctrl and cKO mice. Note microcyst formation and inflammation in smooth muscle layer in the small intestine 
of cKO but not Ctrl (top) and inflammation to and expansion of the muscle layer in colon (middle panel) of cKO but not Ctrl 
mice and significant thickening of the colonic muscular layer (middle panels) and reduced production of mucin in the colon 
(bottom panels).   
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Figure 4.4.  
Apc deletion promote development of Th1 and Th17 cells 
a-b. Apc deletion enhanced accumulation of Th1 and Th17 cells in the spleens, Splenocytes from WT and cKO mice were 
stimulated with PMA and ionomycin for 6 hours prior to intracellular staining with anti-IFN and IL-17A mAbs.  
Representative profiles were shown in a, while the summary data are shown in b.  n=9. c-d. IL-17A production in MLN of 
ctrl or cKO; n=9. e. CD4 SP thymocytes were polarized in Th17 polarizing medium for 5 days and stained for Rort. 
Representative profiles are shown in the left while summary data involving 6 mice per group were shown in the right 
panels.  
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Figure 4.5.  Role for -catenin in HP of Apc-deficient T cells.  a. Efficacy of Ctnnb1 
deletion in T cells.  Genomic DNA was isolated from the purified splenic T cells from 
either Cre- or Cre+ littermates of the Ctnnb1fl/fl mice. Genotype was performed with a set 
of three primers that give distinct sizes for the Floxed (fl) and deleted (del) allele.  b and 
c. Defective homeostatic proliferation of Ctnnb1-/- T cells in a lymphopenic host.  b. 
Representative profiles of WT and Ctnnb1-/- T cells. c. Summary of the data from b with 
3 mice per group. These data have been reproduced twice.    
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Fig 4.6. cMyc activation does not contribute to homeostatic proliferation of Apc-deficient 
T cells.  (a-c) Peripheral blood from ctrl (n=9), cKO (n=9), Myc+/- cKO (n=9), or Myc+/- 
cKO (n=6) were collected from 6-8 week old mice. Red blood cells were lysed. Cells 
were stained for surface markers: CD3, CD4, and CD8, then permealbilized and stained 
for Ki-67. Levels of Ki-67 on CD3+ T cells (a)  CD3+ CD4+  T cells (b) and CD3+CD8+ T 
cells (c) Representative profiles are shown in the left and summary data are presented 
in the right panels. 
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Figure 4.7 
 
 
Figure 4.7 cMyc deletion is insufficient to prevent autoimmune disease in cKO 
mice. Survival curve of ctrl, cKO, Myc+/- cKO, and Myc-/- cKO. Mice were sacrificed 
when determined moribund by: greater than 20% weight loss and bloody diarrhea. 
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Chapter 5 
Concluding Remarks 
Wnt signaling regulates many aspects of T cell development, from early thymocyte 
development to peripheral T cell differentiation and maintenance. However, conflicting 
studies using β-catenin deficient thymocytes challenges the exact functional role Wnt 
plays in thymocyte development. In chapter 2, we sought to readdress the role of Wnt in 
thymocyte development by deleting the regulator of Wnt, Apc. We show that without 
Apc, thymocyte development occurs fairly normally. We did detect increased SP 
thymocyte death, but it was not significantly sufficient to alter SP percentages. Any 
aberrations to thymocyte development could only be seen in the context of a 
competitive reconstitution, as seen in chapter 3.  
This modest difference is a stark contrast to a previous study using a deletion of Apc, 
but with Lck-cre. To verify that the differences observed were not the result of differently 
timed cre promoters, we crossed our Apc deletion to Lck-cre. Unlike the previous study 
which saw a large developmental blockage at the DN3 to DN4 transition, we only saw a 
small decrease of SP thymocytes and age-dependent thymic atrophy. This difference 
may be due to the differences in loxP sites, where the resulting protein in our study was 
slightly larger than what was previously use. It is also possible that in our Lck-cre 
 
 
100 
 
system, Apc was not deleted as efficiently or as early as the previous study, for we have 
yet to test the deletion efficient or timing of our Lck-cre system. 
As previously described, deletion of Apc, under the control of Lck-cre, enhanced thymic 
involution [119]. It is possible that β-catenin accumulation enhances thymic involution by 
mimicking the effects of chronic TCR signaling, though the involvement of Wnt signaling 
is still unknown. Thymic involution, in humans, occurs due to aging. It would be of 
interest to determine whether aged mice have an accumulation of β-catenin in the DN 
compartments, mimicking the accumulation of β-catenin via Lck-cre controlled deletion 
of Apc.  
Because Apc also is involved in many Wnt-independent signaling pathways, it is 
important to determine whether it is the activation of Wnt that affects thymocyte 
development.  Using an exon 3 deletion of β-catenin, where the β-catenin is 
constitutively active, we can verify if Wnt activation will be a phenocopy of our cKO T 
cells. It is possible that many of the phenotypes seen in cKO mice is the result of Wnt-
independent roles of Apc. Future investigations should focus on the roles of Apc that 
are Wnt-independent, such the role of Apc in mitosis (chromosomal segregation and 
cytokinesis), cell migration, DNA repair, and cell cycle control. Further studies are 
needed to determine whether the observed phenotypes are all Wnt-dependent.  
The rather normal thymocyte development in cKO mice gave us a rare opportunity to 
study the role of Apc in naïve T cells. In chapter 3 we reported that Apc deficiency 
causes a massive loss of peripheral naïve T cells. Though Wnt signaling has been 
extensively studied in thymocyte development and mature effector T cells, the role of 
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Wnt signaling in naïve T cells has not yet been recognized. Preliminary evidence have 
shown that Wnt signaling regulation is vital to naïve T cells. Resting human T cells has 
higher levels of both LEF and TCF-1, however, both isoforms expressed are inhibitory 
isoforms [240].   In our study, the ectopic activation of Wnt caused the overexpression 
of cMyc, and T cell loss can be alleviated by reducing cMyc expression.  Though the 
reduction of cMyc in cKO mice does attenuate cell death, naïve T cell numbers are not 
entirely rescued, suggesting that there are other pathways involved in loss of naïve T 
cells.  
Therefore, we investigated whether the loss of Apc could result in increased mTOR 
signaling. We detected higher mTOR signaling in cKO T cells, though it still remains to 
be determined the extent mTOR signaling may play in cKO T cell apoptosis. Perhaps 
most surprising, treatment of rapamycin of cKO mice resulted in a cytokine storm that 
caused the eventual death in over 60% of the cKO mice. Rapamycin, a known inhibitor 
of mTOR, is known as an immunosuppressant, used in prevention of transplantation 
rejection by enhancing Treg expansion by inhibiting the expression of other T effector 
cell types [241-243], diminishing the co-stimulatory abilities of dendritic cells [244, 245], 
and stimulating the release of anti-inflammatory cytokines [197, 246]. However, when 
treated in conjunction with LPS or other TLR agonists, the presence of rapamycin 
incites the production of pro-inflammatory cytokines in dendritic cells [197]. This can 
also be extended into T cells: perhaps, in pro-inflammatory conditions (highly activated 
IFNγ and IL17A-producting cKO T cells), mTOR acts as a negative regulator of the 
production of pro-inflammatory cytokines, TNFα.  
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Future investigations are needed to determine the mechanism by which rapamycin 
treatment induces this production of TNFα in cKO mice. Firstly, it is important to 
determine whether it is the specific inhibition of mTOR that causes pro-inflammatory 
cytokine release. Rapamycin is a pharmaceutical inhibitor that could also affect other 
cellular pathways, therefore, it is important to determine whether rapamycin is not 
causing off-target effects. We need to treat both control and cKO mice with other 
inhibitors of mTOR (torin1/2, MK-866, or RAD001) to verify the inhibition of mTOR 
signaling is the cause of the cytokine storm in cKO mice. Secondly, we need to confirm 
whether the cause of the cytokine storm is cell intrinsic or cell extrinsic (Tregs or innate 
APCs). Though it is well-established that rapamycin promotes the expansion of Tregs 
[241], it is conceivable that inhibition of mTOR signaling in cKO T cells may be affecting 
Treg suppression by affect Treg survival or function (inhibition of IL-10). Therefore, it 
could be a dysfunction of Tregs that allows for the uninhibited production of pro-
inflammatory cytokines. Previously, it has been reported that under conditions of 
inflammation, inhibition of mTOR promotes IL-12 and prevents the production of IL-10 in 
monocytes. Possibly, the treatment of rapamycin affects monocytes, which then in turn 
further activates cKO T cells. Finally, it is also conceivable that the cytokine storm is a 
cell intrinsic effect that causes cKO T cells to become even more activated. Rapamycin 
treatment of LPS treated mice caused increased STAT3 signaling [197]. Perhaps 
increased STAT3 signaling in T cells could be driving the polarization to pathogenic 
Th17 cells in our Apc-deficient, rapamycin-treated T cells. Another possible pathway 
that could be the cause of pro-inflammatory cytokines could be the result of a 
downstream target of mTOR, hypoxia inducible transcription factor (HIF-1α) [247, 248]. 
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It has been shown that HIF-1α deficient T cells causes increased production of pro-
inflammatory cytokines in the context of an in vivo model of bacterial sepsis [249]. By 
inhibiting mTOR signaling, HIF-1α may also be reduced, thus resulting in increased pro-
inflammatory cytokine production. Therefore, further studies are necessary to determine 
if the inhibition of mTOR is the cause of the cytokine storm and whether this production 
of pro-inflammatory is cell intrinsic or cell extrinsic programming. 
Due to the fact that deletion of cMyc did not fully rescue naïve T cell apoptosis and the 
observation that both the intrinsic and extrinsic pathways of apoptosis are involved, we 
sought to look for other pathways involved in naïve T cell apoptosis. Another possible 
mechanism involved in the survival defect of the naïve cKO T cells is the p53 pathway. 
p53 upregulation is the result of cellular stress, including: genotoxicity [250-254], 
cytokines [250, 255], hypoxia [256, 257], activated oncogenes [258], growth factors 
[259-261], and metabolic changes [193, 262].  We determined that p53 is upregulated in 
cKO T cells. It is important to define the mechanism by which p53 is upregulated. A 
deletion of Apc may cause chromosomal instability, thus causing the upregulation of 
p53 [58, 71]. It is also possible that the deletion of Apc causes the accumulation of β-
catenin, causing oncogene-induced p53 expression. It has been previously shown that 
β-catenin accumulation can activate ARF, which in turn, will cause p53 expression 
[263]. In addition, constitutive mTOR activation has been shown to activate p53 [193, 
262]. It will be of interest to determine whether in vitro rapamycin treated cKO T cells 
will affect p53 expression. cMyc has also been implicated as a requirement in p53-
induced apoptosis due to DNA damage [198]. It still remains to be determined whether 
cKO cMyc-/-  T cell apoptosis involves p53. 
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To improve our investigation of the role of Apc in naïve T cells, we need to verify that 
these subtle aberrations in bone marrow chimera SP thymocyte development did not 
affect the phenotypes we observed in naïve T cells. In this study, we focused on the role 
of Apc in Wnt, but Apc plays many other roles, including chromosomal stability. By 
deleting Apc at a much earlier time point, we could be causing genomic instability that 
may also be contributing to cell death in naïve T cell. Changing to a different cre, distal 
lck-cre, may also help elucidate the role of Apc in naïve T cells. Distal Lck-cre deletion 
begins much later than CD4-cre. CD4-cre is already active during the neonatal 
lymphopenic period, while dLck-cre occurs slowly in the peripheral T cells. By altering 
the cre promoter, we will be able to better examine the role of Apc, specifically in naïve 
T cells. 
Finally, in chapter 4, we investigated the role of Apc lymphopenia-driven homeostatic 
proliferation and autoimmune disease. We showed that the loss of Apc and the resulting 
lymphopenia instigated a Crohn’s disease-like autoimmune disease. This study is the 
first to show a single gene deletion having the ability to sufficiently initiate autoimmune 
disease in a context of lymphopenia due to the highly activated nature of cKO T cells, 
but also the hyperproliferation capabilities of activated Wnt T cells. Factors that can 
affect optimal homeostatic proliferation include the influence of extrinsic factors 
(cytokines, commensal bacteria, and T regulator cells) and also intrinsic factors (TCR 
stimulation and co-stimulator molecules); further studies are necessary to determine the 
extent each of these factors may contribute to the development of autoimmune disease 
seen in cKO mice. Wnt signaling may be important for T regulatory cell function and/or 
survival [120-122]. It is possible that cKO T regulatory cells may be unable to suppress 
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the homeostatic proliferation of cKO T cells, allowing for the development of disease, 
rather than an enhanced ability to homeostatically proliferate. Using naïve T cell transfer 
to Rag1-/- mice, we plan to clarify the function of T regulatory cells in causing 
autoimmune disease in cKO mice.  Commensal bacteria are another factor that can 
influence homeostatic proliferation because these bacteria provide inflammatory signals 
and antigens that are required for the development of autoimmunity in the context of 
lymphopenic environments. Antibiotic treatment of recipient Rag1-/- before transfer of 
naïve T cells will verify the involvement of commensal bacteria in driving homeostatic 
proliferation-driven lymphopenia in cKO mice. Finally, to delineate the degree TCR 
stimulation plays a role in the hyperproliferation of cKO T cells, using OT-I cKO, we 
could determine the proliferation to either a weak or strong TCR stimulation.  Also 
breeding cKO mice to an OT-1 background would allow us to investigate whether this 
hyperproliferation requires TCR/MHC interaction to proliferative. Detection of CD5 on 
cKO T cells may also determine the levels of TCR stimulation. Mechanistically, these 
studies will assist our understanding of Wnt signaling post-TCR stimulation. TCR 
stimulation is often followed by the accumulation/stabilization of β-catenin [104], 
however the physiological significance is still unclear. Perhaps, cKO T cells are 
hyperproliferative because of the higher levels of β-catenin causing these T cells to 
have hypersensitive TCRs.  
The etiology of Crohn’s disease is still unknown, however, recent human studies have 
shown a link between the incidence of Crohn’s disease and a reduction of diversity of 
the patients’ microbiota [264, 265].  It is still unknown what causes this shift in 
microbiota, whether it is an ineffective immune system that cannot clear an infection or if 
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it is the host’s immune cells that drives the colonization of more pathogenic bacteria. It 
would be of interest to determine whether if the cytokine milieu produced by Apc 
deficient T cells is sufficiently alters the microbiota, which then instigates the 
development of the Crohn’s like disease in cKO mice. We have shown the Apc deficient 
T cells produce more IFNγ and IL-17A, which could possibly affect the homeostasis of 
commensal bacteria, allowing for the colonization of more pathogenic bacteria leading 
to a severe pro-inflammatory response driving the development of autoimmunity. It is 
also possible that Apc deficient T cells are ineffective at clearing infections, which then 
allow for the colonization of pathogenic bacteria. Either hypothesizes provide an 
interesting insight in how the microbiota and T cells may both play a role in the 
development of Crohn’s disease. 
This study has shown that Apc is not essential in later stages of thymocyte development 
nor thymic emigration. Instead we found that regulation of Apc is essential in the 
maintenance of naïve T cells. Our insight into the intracellular programs, which 
regulates the maintenance of a peripheral pool of incredibility diverse repertoire of naïve 
T cells, plays an essential role in our understanding of how the adaptive immune system 
responses to an assortment of foreign antigens. By retaining these naïve T cells in a 
quiescence state, these intrinsic programs allow for the suppression of the development 
of autoimmune disease by restraining the acquisition effector traits. Previously, the 
mTOR pathway has been shown to play a vital role in holding naïve T cell quiescence 
[97, 98].  Rather, the survival of naïve T cells require Apc to regulate Wnt signaling in 
order to maintain both low levels of cMyc and mTOR signaling. By deleting Apc, we also 
show that Wnt signaling is necessary for an optimal homeostatic proliferation. 
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Constitutively activating Wnt results in a highly inflammatory cKO T cell that leads the 
development of a Crohn’s disease-like autoimmune disease. 
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